Scholars@Duke

• Background
• 

  Education, Training, & Certifications

  • Ph.D., Yale University 1984
• 

  Duke Appointment History

  • Associate Professor of Biostatistics and Bioinformatics, Biostatistics & Bioinformatics, Basic Science Departments 2013 - 2019
  • Assistant Professor of Biostatistics and Bioinformatics, Biostatistics & Bioinformatics, Basic Science Departments 2007 - 2013
  • Assistant Research Professor of Biostatistics and Bioinformatics, Biostatistics & Bioinformatics, Basic Science Departments 2000 - 2007
  • Assistant Research Professor in Community and Family Medicine, Family Medicine and Community Health, Clinical Science Departments 1997 - 2000
  • Instructor, Temporary in the Department of Community and Family Medicine, Family Medicine and Community Health, Clinical Science Departments 1997
• Research
• 

  Selected Grants

  • Role of ALK4 in Regulating Receptor Trafficking and Pancreatic Cancer Biology awarded by National Institutes of Health 2019 - 2024
  • Role for TbetaRIII Shedding in the Tumor Microenvironment awarded by National Institutes of Health 2019 - 2024
  • Hybrid virtual-MRI/CBCT: A new paradigm for image guidance in liver SBRT awarded by National Institutes of Health 2019 - 2023
  • The role of gastrin in esophageal submucosal gland acinar ductal metaplasia awarded by National Institutes of Health 2018 - 2023
  • Effects of storage method on intestinal allograft immune profile and viability awarded by Department of Defense 2019 - 2021
  • Duke-UNC-Wash U Partnership for Early Phase Clinical Trials in Cancer awarded by National Institutes of Health 2014 - 2021
  • The Impact of Race, Ethnicity, and Socioeconomic Status on Listing for Liver Transplant after Referral awarded by American Association for the Study of Liver Diseases 2018 - 2020
  • National Clinical Trials Network - Network Group Statistics and DMCs awarded by Mayo Clinic 2014 - 2017
  • Impact of Celecoxib and Inflammation on Surival in Stage III Colon Cancer awarded by Dana Farber Cancer Institute 2016 - 2017
  • Dietary & Lifestyle Determinants of Colon Cancer Recurrence & Survival awarded by Dana Farber Cancer Institute 2007 - 2017
  • The Influence of Diet and Lifestyle on Patients with Advanced Colorectal Cancer awarded by Dana Farber Cancer Institute 2015 - 2016
  • Mayo Alliance Foundation Funds 2012 - 2014
  • Graft Engineering and Immunotherapy After Unrelated Cord Blood Transplantation awarded by National Institutes of Health 2007 - 2011
  • Cancer and Leukemia Group B Statistical Center awarded by National Institutes of Health 1982 - 2010
  • Targeting hCG-beta for Breast Cancer Immunotherapy awarded by National Institutes of Health 2004 - 2009
  • Vaccination with Regulatory T Cell Depletion awarded by National Institutes of Health 2006 - 2008
  • Immunotherapy using peptide MHC tetramer isolated Tcells awarded by National Institutes of Health 2002 - 2007
  • Planning a Duke Academic Public Private Partnership Program (AP4) Center awarded by National Cancer Institute 2004 - 2006
  • Elimination of Regulatory T Cells awarded by National Institutes of Health 2003 - 2005
  • Prospective comparison of colonic imaging tests awarded by National Institutes of Health 2000 - 2005
  • Immunotherapy with Renal Tumor RNA Transfected Dendritic Cells awarded by National Institutes of Health 2001 - 2005
  • Dexasome Based Immunotherapy of Lung Cancer awarded by National Institutes of Health 2001 - 2004
  • Immunotherapy with TRICOM Modified Dendritic Cells awarded by National Institutes of Health 2001 - 2003
• Publications & Artistic Works
• 

  Selected Publications

  • Academic Articles

    • Yuan, Chen, Kaori Sato, Bruce W. Hollis, Sui Zhang, Donna Niedzwiecki, Fang-Shu Ou, I-Wen Chang, et al. “Plasma 25-Hydroxyvitamin D Levels and Survival in Patients with Advanced or Metastatic Colorectal Cancer: Findings from CALGB/SWOG 80405 (Alliance)..” Clin Cancer Res 25, no. 24 (December 15, 2019): 7497–7505. https://doi.org/10.1158/1078-0432.CCR-19-0877.
       Full Text  Link to Item
    • Ronellenfitsch, Ulrich, Katrin Jensen, Svenja Seide, Meinhard Kieser, Matthias Schwarzbach, Tracy E. Slanger, Bryan Burmeister, et al. “Disease-free survival as a surrogate for overall survival in neoadjuvant trials of gastroesophageal adenocarcinoma: Pooled analysis of individual patient data from randomised controlled trials..” Eur J Cancer 123 (December 2019): 101–11. https://doi.org/10.1016/j.ejca.2019.10.001.
       Full Text  Link to Item
    • Vernuccio, Federica, Devon Godfrey, Mathias Meyer, Hannah V. Williamson, Joseph K. Salama, Donna Niedzwiecki, Sarah Jo Stephens, James Ronald, Manisha Palta, and Daniele Marin. “Local Tumor Control and Patient Outcome Using Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: iRECIST as a Potential Substitute for Traditional Criteria..” Ajr Am J Roentgenol 213, no. 6 (December 2019): 1232–39. https://doi.org/10.2214/AJR.18.20842.
       Full Text  Link to Item
    • Strickler, John H., Christel N. Rushing, Donna Niedzwiecki, Abigail McLeod, Ivy Altomare, Hope E. Uronis, S David Hsu, et al. “A phase Ib study of capecitabine and ziv-aflibercept followed by a phase II single-arm expansion cohort in chemotherapy refractory metastatic colorectal cancer..” Bmc Cancer 19, no. 1 (November 1, 2019). https://doi.org/10.1186/s12885-019-6234-8.
       Full Text  Link to Item
    • Guercio, Brendan J., Sui Zhang, Fang-Shu Ou, Alan P. Venook, Donna Niedzwiecki, Heinz-Josef Lenz, Federico Innocenti, et al. “Associations of Physical Activity With Survival and Progression in Metastatic Colorectal Cancer: Results From Cancer and Leukemia Group B (Alliance)/SWOG 80405..” J Clin Oncol 37, no. 29 (October 10, 2019): 2620–31. https://doi.org/10.1200/JCO.19.01019.
       Full Text  Link to Item
    • Clarke, Jeffrey Melson, Gerard C. Blobe, John H. Strickler, Hope Elizabeth Uronis, S Yousuf Zafar, Michael Morse, Evan Dropkin, et al. “A phase Ib study of the combination regorafenib with PF-03446962 in patients with refractory metastatic colorectal cancer (REGAL-1 trial)..” Cancer Chemother Pharmacol 84, no. 4 (October 2019): 909–17. https://doi.org/10.1007/s00280-019-03916-0.
       Full Text  Link to Item
    • Dienstmann, R., G. Villacampa, A. Sveen, M. J. Mason, D. Niedzwiecki, A. Nesbakken, V. Moreno, R. S. Warren, R. A. Lothe, and J. Guinney. “Relative contribution of clinicopathological variables, genomic markers, transcriptomic subtyping and microenvironment features for outcome prediction in stage II/III colorectal cancer..” Ann Oncol 30, no. 10 (October 1, 2019): 1622–29. https://doi.org/10.1093/annonc/mdz287.
       Full Text  Link to Item
    • Galan, Diego, Karen Monuszko, Eric W. Sankey, Rasheedat Zakare-Fagbamila, Zidanyue Yang, Donna Niedzwiecki, Oren Gottfried, Carlos A. Bagley, and Max O. Krucoff. “Fibrin glue as an adjuvant dural sealant reduces the rate of perioperative complications in posterior fossa decompression with duraplasty: A single center experience in 165 adult Chiari I patients..” J Clin Neurosci 68 (October 2019): 80–85. https://doi.org/10.1016/j.jocn.2019.07.036.
       Full Text  Link to Item
    • Griffin, Andrew, Vanessa Reese, Zeynep Hüseyinoglu, Donna Niedzwiecki, Lexie Yang, Andrew Cutler, L Fernando Gonzalez, Ali Zomorodi, Tony Smith, and Erik F. Hauck. “Predictors of Clinical Outcome After Treatment of Intracranial Aneurysms with the Pipeline Embolization Device..” World Neurosurg 130 (October 2019): e666–71. https://doi.org/10.1016/j.wneu.2019.06.185.
       Full Text  Link to Item
    • Abou-Alfa, Ghassan K., Qian Shi, Jennifer J. Knox, Andreas Kaubisch, Donna Niedzwiecki, James Posey, Benjamin R. Tan, et al. “Assessment of Treatment With Sorafenib Plus Doxorubicin vs Sorafenib Alone in Patients With Advanced Hepatocellular Carcinoma: Phase 3 CALGB 80802 Randomized Clinical Trial..” Jama Oncol, September 5, 2019. https://doi.org/10.1001/jamaoncol.2019.2792.
       Full Text  Link to Item
    • Innocenti, Federico, Fang-Shu Ou, Xueping Qu, Tyler Zemla, Donna Niedzwiecki, Rachel Tam, Shilpi Mahajan, et al. “Reply to S. Sorscher..” J Clin Oncol 37, no. 25 (September 1, 2019): 2291–93. https://doi.org/10.1200/JCO.19.01366.
       Full Text  Link to Item
    • Innocenti, Federico, Chen Jiang, Alexander B. Sibley, Stefanie Denning, Amy S. Etheridge, Dorothy Watson, Donna Niedzwiecki, et al. “An initial genetic analysis of gemcitabine-induced high-grade neutropenia in pancreatic cancer patients in CALGB 80303 (Alliance)..” Pharmacogenet Genomics 29, no. 6 (August 2019): 123–31. https://doi.org/10.1097/FPC.0000000000000375.
       Full Text  Link to Item
    • Lenz, Heinz-Josef, Fang-Shu Ou, Alan P. Venook, Howard S. Hochster, Donna Niedzwiecki, Richard M. Goldberg, Robert J. Mayer, et al. “Impact of Consensus Molecular Subtype on Survival in Patients With Metastatic Colorectal Cancer: Results From CALGB/SWOG 80405 (Alliance)..” J Clin Oncol 37, no. 22 (August 1, 2019): 1876–85. https://doi.org/10.1200/JCO.18.02258.
       Full Text  Link to Item
    • Innocenti, Federico, Fang-Shu Ou, Xueping Qu, Tyler J. Zemla, Donna Niedzwiecki, Rachel Tam, Shilpi Mahajan, et al. “Mutational Analysis of Patients With Colorectal Cancer in CALGB/SWOG 80405 Identifies New Roles of Microsatellite Instability and Tumor Mutational Burden for Patient Outcome..” J Clin Oncol 37, no. 14 (May 10, 2019): 1217–27. https://doi.org/10.1200/JCO.18.01798.
       Full Text  Link to Item
    • Kosumi, Keisuke, Tsuyoshi Hamada, Sui Zhang, Li Liu, Annacarolina da Silva, Hideo Koh, Tyler S. Twombly, et al. “Prognostic association of PTGS2 (COX-2) over-expression according to BRAF mutation status in colorectal cancer: Results from two prospective cohorts and CALGB 89803 (Alliance) trial..” Eur J Cancer 111 (April 2019): 82–93. https://doi.org/10.1016/j.ejca.2019.01.022.
       Full Text  Link to Item
    • Morales-Oyarvide, Vicente, Chen Yuan, Ana Babic, Sui Zhang, Donna Niedzwiecki, Jennie C. Brand-Miller, Laura Sampson-Kent, et al. “Dietary Insulin Load and Cancer Recurrence and Survival in Patients With Stage III Colon Cancer: Findings From CALGB 89803 (Alliance)..” J Natl Cancer Inst 111, no. 2 (February 1, 2019): 170–79. https://doi.org/10.1093/jnci/djy098.
       Full Text  Link to Item
    • Corrigan, Kelsey L., Hannah Williamson, Danielle Elliott Range, Donna Niedzwiecki, David M. Brizel, and Yvonne M. Mowery. “Treatment Outcomes in Anaplastic Thyroid Cancer..” J Thyroid Res 2019 (2019). https://doi.org/10.1155/2019/8218949.
       Full Text  Link to Item
    • Hong, Julian C., Donna Niedzwiecki, Manisha Palta, and Jessica D. Tenenbaum. “Predicting Emergency Visits and Hospital Admissions During Radiation and Chemoradiation: An Internally Validated Pretreatment Machine Learning Algorithm..” Jco Clin Cancer Inform 2 (December 2018): 1–11. https://doi.org/10.1200/CCI.18.00037.
       Full Text  Link to Item
    • Innocenti, Federico, Chen Jiang, Alexander B. Sibley, Amy S. Etheridge, Ace J. Hatch, Stefanie Denning, Donna Niedzwiecki, et al. “Genetic variation determines VEGF-A plasma levels in cancer patients..” Sci Rep 8, no. 1 (November 5, 2018). https://doi.org/10.1038/s41598-018-34506-4.
       Full Text  Link to Item
    • Li, Megan, Flora Mulkey, Chen Jiang, Bert H. O’Neil, Bryan P. Schneider, Fei Shen, Paula N. Friedman, et al. “Identification of a Genomic Region between SLC29A1 and HSP90AB1 Associated with Risk of Bevacizumab-Induced Hypertension: CALGB 80405 (Alliance)..” Clin Cancer Res 24, no. 19 (October 1, 2018): 4734–44. https://doi.org/10.1158/1078-0432.CCR-17-1523.
       Full Text  Link to Item
    • Van Blarigan, Erin L., Fang-Shu Ou, Donna Niedzwiecki, Sui Zhang, Charles S. Fuchs, Leonard Saltz, Robert J. Mayer, et al. “Dietary Fat Intake after Colon Cancer Diagnosis in Relation to Cancer Recurrence and Survival: CALGB 89803 (Alliance)..” Cancer Epidemiol Biomarkers Prev 27, no. 10 (October 2018): 1227–30. https://doi.org/10.1158/1055-9965.EPI-18-0487.
       Full Text  Link to Item
    • Proeschold-Bell, Rae Jean, Donna M. Evon, Christina Makarushka, John B. Wong, Santanu K. Datta, Jia Yao, Ashwin A. Patkar, et al. “The Hepatitis C-Alcohol Reduction Treatment (Hep ART) intervention: Study protocol of a multi-center randomized controlled trial..” Contemp Clin Trials 72 (September 2018): 73–85. https://doi.org/10.1016/j.cct.2018.07.003.
       Full Text  Link to Item
    • Innocenti, F., K. Owzar, C. Jiang, A. S. Etheridge, R. Gordân, A. B. Sibley, F. Mulkey, et al. “The Vitamin D receptor gene as a determinant of survival in pancreatic cancer patients: Genomic analysis and experimental validation.” Plos One 13, no. 8 (August 1, 2018). https://doi.org/10.1371/journal.pone.0202272.
       Full Text
    • Kahokehr, Arman A., and Andrew C. Peterson. “Author Reply..” Urology 116 (June 2018): 191–92. https://doi.org/10.1016/j.urology.2018.01.055.
       Full Text  Link to Item
    • Van Blarigan, Erin L., Charles S. Fuchs, Donna Niedzwiecki, Sui Zhang, Leonard B. Saltz, Robert J. Mayer, Rex B. Mowat, et al. “Association of Survival With Adherence to the American Cancer Society Nutrition and Physical Activity Guidelines for Cancer Survivors After Colon Cancer Diagnosis: The CALGB 89803/Alliance Trial..” Jama Oncol 4, no. 6 (June 1, 2018): 783–90. https://doi.org/10.1001/jamaoncol.2018.0126.
       Full Text  Link to Item
    • Fadelu, Temidayo, Sui Zhang, Donna Niedzwiecki, Xing Ye, Leonard B. Saltz, Robert J. Mayer, Rex B. Mowat, et al. “Nut Consumption and Survival in Patients With Stage III Colon Cancer: Results From CALGB 89803 (Alliance)..” J Clin Oncol 36, no. 11 (April 10, 2018): 1112–20. https://doi.org/10.1200/JCO.2017.75.5413.
       Full Text  Link to Item
    • Fuchs, Charles S., and Donna Niedzwiecki. “Reply to L. Fornaro et al..” J Clin Oncol 36, no. 11 (April 10, 2018): 1179–80. https://doi.org/10.1200/JCO.2017.77.1030.
       Full Text  Link to Item
    • Van Blarigan, Erin L., Charles S. Fuchs, Donna Niedzwiecki, Xing Ye, Sui Zhang, Mingyang Song, Leonard B. Saltz, et al. “Marine ω-3 Polyunsaturated Fatty Acid and Fish Intake after Colon Cancer Diagnosis and Survival: CALGB 89803 (Alliance)..” Cancer Epidemiol Biomarkers Prev 27, no. 4 (April 2018): 438–45. https://doi.org/10.1158/1055-9965.EPI-17-0689.
       Full Text  Link to Item
    • Grothey, Axel, Alberto F. Sobrero, Anthony F. Shields, Takayuki Yoshino, James Paul, Julien Taieb, John Souglakos, et al. “Duration of Adjuvant Chemotherapy for Stage III Colon Cancer..” N Engl J Med 378, no. 13 (March 29, 2018): 1177–88. https://doi.org/10.1056/NEJMoa1713709.
       Full Text  Link to Item
    • Brown, Justin C., Sui Zhang, Donna Niedzwiecki, Leonard B. Saltz, Robert J. Mayer, Rex B. Mowat, Renaud Whittom, et al. “Grain Intake and Clinical Outcome in Stage III Colon Cancer: Results From CALGB 89803 (Alliance)..” Jnci Cancer Spectr 2, no. 2 (February 2018). https://doi.org/10.1093/jncics/pky017.
       Full Text  Link to Item
    • Strickler, John H., Jonathan M. Loree, Leanne G. Ahronian, Aparna R. Parikh, Donna Niedzwiecki, Allan Andresson Lima Pereira, Matthew McKinney, et al. “Genomic Landscape of Cell-Free DNA in Patients with Colorectal Cancer..” Cancer Discov 8, no. 2 (February 2018): 164–73. https://doi.org/10.1158/2159-8290.CD-17-1009.
       Full Text  Link to Item
    • Guercio, Brendan J., Sui Zhang, Donna Niedzwiecki, Yanping Li, Ana Babic, Vicente Morales-Oyarvide, Leonard B. Saltz, et al. “Associations of artificially sweetened beverage intake with disease recurrence and mortality in stage III colon cancer: Results from CALGB 89803 (Alliance)..” Plos One 13, no. 7 (2018). https://doi.org/10.1371/journal.pone.0199244.
       Full Text  Link to Item
    • Innocenti, Federico, Kouros Owzar, Chen Jiang, Amy S. Etheridge, Raluca Gordân, Alexander B. Sibley, Flora Mulkey, et al. “The vitamin D receptor gene as a determinant of survival in pancreatic cancer patients: Genomic analysis and experimental validation..” Plos One 13, no. 8 (2018). https://doi.org/10.1371/journal.pone.0202272.
       Full Text  Link to Item
    • Fuchs, Charles S., Donna Niedzwiecki, Harvey J. Mamon, Joel E. Tepper, Xing Ye, Richard S. Swanson, Peter C. Enzinger, et al. “Adjuvant Chemoradiotherapy With Epirubicin, Cisplatin, and Fluorouracil Compared With Adjuvant Chemoradiotherapy With Fluorouracil and Leucovorin After Curative Resection of Gastric Cancer: Results From CALGB 80101 (Alliance)..” J Clin Oncol 35, no. 32 (November 10, 2017): 3671–77. https://doi.org/10.1200/JCO.2017.74.2130.
       Full Text  Link to Item
    • Ronellenfitsch, U., M. Schwarzbach, R. Hofheinz, P. Kienle, K. Nowak, M. Kieser, T. E. Slanger, et al. “Predictors of overall and recurrence-free survival after neoadjuvant chemotherapy for gastroesophageal adenocarcinoma: Pooled analysis of individual patient data (IPD) from randomized controlled trials (RCTs)..” Eur J Surg Oncol 43, no. 8 (August 2017): 1550–58. https://doi.org/10.1016/j.ejso.2017.05.005.
       Full Text  Link to Item
    • Erhunmwunsee, Loretta, Brian C. Gulack, Christel Rushing, Donna Niedzwiecki, Mark F. Berry, and Matthew G. Hartwig. “Socioeconomic Status, Not Race, Is Associated With Reduced Survival in Esophagectomy Patients..” Ann Thorac Surg 104, no. 1 (July 2017): 234–44. https://doi.org/10.1016/j.athoracsur.2017.01.049.
       Full Text  Link to Item
    • Venook, Alan P., Donna Niedzwiecki, Heinz-Josef Lenz, Federico Innocenti, Briant Fruth, Jeffrey A. Meyerhardt, Deborah Schrag, et al. “Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical Trial..” Jama 317, no. 23 (June 20, 2017): 2392–2401. https://doi.org/10.1001/jama.2017.7105.
       Full Text  Link to Item
    • Fuchs, M. A., C. Yuan, K. Sato, D. Niedzwiecki, X. Ye, L. B. Saltz, R. J. Mayer, et al. “Predicted vitamin D status and colon cancer recurrence and mortality in CALGB 89803 (Alliance)..” Ann Oncol 28, no. 6 (June 1, 2017): 1359–67. https://doi.org/10.1093/annonc/mdx109.
       Full Text  Link to Item
    • Niedzwiecki, Donna, Wendy L. Frankel, Alan P. Venook, Xing Ye, Paula N. Friedman, Richard M. Goldberg, Robert J. Mayer, et al. “Reply to L. Casadaban et al..” J Clin Oncol 35, no. 12 (April 20, 2017): 1373–74. https://doi.org/10.1200/JCO.2016.71.2646.
       Full Text  Link to Item
    • Riedel, Richard F., Kellen L. Meadows, Paula H. Lee, Michael A. Morse, Hope E. Uronis, Gerard C. Blobe, Daniel J. George, et al. “Phase I study of pazopanib plus TH-302 in advanced solid tumors..” Cancer Chemother Pharmacol 79, no. 3 (March 2017): 611–19. https://doi.org/10.1007/s00280-017-3256-2.
       Full Text  Link to Item
    • Niedzwiecki, Donna, Rian M. Hasson, Heinz-Josef Lenz, Cynthia Ye, Mark Redston, Shuji Ogino, Charles S. Fuchs, et al. “A Study of Thymidylate Synthase Expression as a Biomarker for Resectable Colon Cancer: Alliance (Cancer and Leukemia Group B) 9581 and 89803..” Oncologist 22, no. 1 (January 2017): 107–14. https://doi.org/10.1634/theoncologist.2016-0215.
       Full Text  Link to Item
    • Hatch, Ace J., Alexander B. Sibley, Mark D. Starr, J Chris Brady, Chen Jiang, Jingquan Jia, Daniel L. Bowers, et al. “Blood-based markers of efficacy and resistance to cetuximab treatment in metastatic colorectal cancer: results from CALGB 80203 (Alliance)..” Cancer Med 5, no. 9 (September 2016): 2249–60. https://doi.org/10.1002/cam4.806.
       Full Text  Link to Item
    • Niedzwiecki, Donna, Wendy L. Frankel, Alan P. Venook, Xing Ye, Paula N. Friedman, Richard M. Goldberg, Robert J. Mayer, et al. “Association Between Results of a Gene Expression Signature Assay and Recurrence-Free Interval in Patients With Stage II Colon Cancer in Cancer and Leukemia Group B 9581 (Alliance)..” J Clin Oncol 34, no. 25 (September 1, 2016): 3047–53. https://doi.org/10.1200/JCO.2015.65.4699.
       Full Text  Link to Item
    • Enzinger, Peter C., Barbara Ann Burtness, Donna Niedzwiecki, Xing Ye, Kathe Douglas, David H. Ilson, Victoria Meucci Villaflor, et al. “CALGB 80403 (Alliance)/E1206: A Randomized Phase II Study of Three Chemotherapy Regimens Plus Cetuximab in Metastatic Esophageal and Gastroesophageal Junction Cancers..” J Clin Oncol 34, no. 23 (August 10, 2016): 2736–42. https://doi.org/10.1200/JCO.2015.65.5092.
       Full Text  Link to Item
    • Hochster, Howard S., and Donna Niedzwiecki. “Big Data, Small Effects..” J Clin Oncol 34, no. 11 (April 10, 2016): 1170–71. https://doi.org/10.1200/JCO.2015.65.8161.
       Full Text  Link to Item
    • Kulke, Matthew H., Donna Niedzwiecki, Nathan R. Foster, Briant Fruth, Pamela L. Kunz, Hagen Kennecke, Edward M. Wolin, and Alan P. Venook. “Randomized Phase II Study of Everolimus (E) Versus Everolimus plus Bevacizumab (E plus B) in Patients (Pts) With Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors (pNET), CALGB 80701 (Alliance).” Pancreas 45, no. 3 (March 1, 2016): 477–477.
       Link to Item
    • Guercio, Brendan J., Kaori Sato, Donna Niedzwiecki, Xing Ye, Leonard B. Saltz, Robert J. Mayer, Rex B. Mowat, et al. “Coffee Intake, Recurrence, and Mortality in Stage III Colon Cancer: Results From CALGB 89803 (Alliance)..” J Clin Oncol 33, no. 31 (November 1, 2015): 3598–3607. https://doi.org/10.1200/JCO.2015.61.5062.
       Full Text  Link to Item
    • Meadows, Kellen L., Christel Rushing, Wanda Honeycutt, Kenneth Latta, Leigh Howard, Christy A. Arrowood, Donna Niedzwiecki, and Herbert I. Hurwitz. “Treatment of palmar-plantar erythrodysesthesia (PPE) with topical sildenafil: a pilot study..” Support Care Cancer 23, no. 5 (May 2015): 1311–19. https://doi.org/10.1007/s00520-014-2465-z.
       Full Text  Link to Item
    • Cushman, Stephanie M., Chen Jiang, Ace J. Hatch, Ivo Shterev, Alexander B. Sibley, Donna Niedzwiecki, Alan P. Venook, Kouros Owzar, Herbert I. Hurwitz, and Andrew B. Nixon. “Gene expression markers of efficacy and resistance to cetuximab treatment in metastatic colorectal cancer: results from CALGB 80203 (Alliance)..” Clin Cancer Res 21, no. 5 (March 1, 2015): 1078–86. https://doi.org/10.1158/1078-0432.CCR-14-2313.
       Full Text  Link to Item
    • Ng, Kimmie, Jeffrey A. Meyerhardt, Andrew T. Chan, Kaori Sato, Jennifer A. Chan, Donna Niedzwiecki, Leonard B. Saltz, et al. “Aspirin and COX-2 inhibitor use in patients with stage III colon cancer..” J Natl Cancer Inst 107, no. 1 (January 2015). https://doi.org/10.1093/jnci/dju345.
       Full Text  Link to Item
    • Renfro, Lindsay A., Axel M. Grothey, James Paul, Irene Floriani, Franck Bonnetain, Donna Niedzwiecki, Takeharu Yamanaka, Ioannis Souglakos, Greg Yothers, and Daniel J. Sargent. “Projecting Event-Based Analysis Dates in Clinical Trials: An Illustration Based on the International Duration Evaluation of Adjuvant Chemotherapy (IDEA) Collaboration. Projecting analysis dates for the IDEA collaboration..” Forum Clin Oncol 5, no. 2 (December 2014): 1–7. https://doi.org/10.2478/fco-2014-0006.
       Full Text  Link to Item
    • Shiovitz, Stacey, Monica M. Bertagnolli, Lindsay A. Renfro, Eunmi Nam, Nathan R. Foster, Slavomir Dzieciatkowski, Yanxin Luo, et al. “CpG island methylator phenotype is associated with response to adjuvant irinotecan-based therapy for stage III colon cancer..” Gastroenterology 147, no. 3 (September 2014): 637–45. https://doi.org/10.1053/j.gastro.2014.05.009.
       Full Text  Link to Item
    • Van Loon, Katherine, Kouros Owzar, Chen Jiang, Hedy L. Kindler, Mary F. Mulcahy, Donna Niedzwiecki, Eileen M. O’Reilly, et al. “25-Hydroxyvitamin D levels and survival in advanced pancreatic cancer: findings from CALGB 80303 (Alliance)..” J Natl Cancer Inst 106, no. 8 (August 2014). https://doi.org/10.1093/jnci/dju185.
       Full Text  Link to Item
    • Venook, Alan P., Donna Niedzwiecki, Heinz-Josef Lenz, Federico Innocenti, Michelle R. Mahoney, Bert H. O’Neil, James Edward Shaw, et al. “CALGB/SWOG 80405: Phase III trial of irinotecan/5-FU/leucovorin (FOLFIRI) or oxaliplatin/5-FU/leucovorin (mFOLFOX6) with bevacizumab (BV) or cetuximab (CET) for patients (pts) with KRAS wild-type (wt) untreated metastatic adenocarcinoma of the colon or rectum (MCRC)..” Journal of Clinical Oncology 32, no. 18 (June 20, 2014).
       Link to Item
    • Parikh, Suhag H., Adam Mendizabal, Cara L. Benjamin, Krishna V. Komanduri, Jeyaraj Antony, Aleksandra Petrovic, Gregory Hale, et al. “A novel reduced-intensity conditioning regimen for unrelated umbilical cord blood transplantation in children with nonmalignant diseases..” Biol Blood Marrow Transplant 20, no. 3 (March 2014): 326–36. https://doi.org/10.1016/j.bbmt.2013.11.021.
       Full Text  Link to Item
    • Fuchs, Michael A., Kaori Sato, Donna Niedzwiecki, Xing Ye, Leonard B. Saltz, Robert J. Mayer, Rex B. Mowat, et al. “Sugar-sweetened beverage intake and cancer recurrence and survival in CALGB 89803 (Alliance)..” Plos One 9, no. 6 (2014). https://doi.org/10.1371/journal.pone.0099816.
       Full Text  Link to Item
    • Parikh, S. H., A. Mendizabal, C. L. Benjamin, K. V. Komanduri, J. Antony, A. Petrovic, G. Hale, et al. “A novel reduced-intensity conditioning regimen for unrelated umbilical cord blood transplantation in children with nonmalignant diseases.” Biology of Blood and Marrow Transplantation 20, no. 3 (2014): 326–36.
    • Pavelitz, Thomas, Lindsay Renfro, Nathan R. Foster, Amber Caracol, Piri Welsch, Victoria Valinluck Lao, William B. Grady, et al. “MRE11-deficiency associated with improved long-term disease free survival and overall survival in a subset of stage III colon cancer patients in randomized CALGB 89803 trial..” Plos One 9, no. 10 (2014). https://doi.org/10.1371/journal.pone.0108483.
       Full Text  Link to Item
    • Ogino, Shuji, Xiaoyun Liao, Yu Imamura, Mai Yamauchi, Nadine J. McCleary, Kimmie Ng, Donna Niedzwiecki, et al. “Predictive and prognostic analysis of PIK3CA mutation in stage III colon cancer intergroup trial..” J Natl Cancer Inst 105, no. 23 (December 4, 2013): 1789–98. https://doi.org/10.1093/jnci/djt298.
       Full Text  Link to Item
    • Jeon, Justin, Kaori Sato, Donna Niedzwiecki, Xing Ye, Leonard B. Saltz, Robert J. Mayer, Rex B. Mowat, et al. “Impact of physical activity after cancer diagnosis on survival in patients with recurrent colon cancer: Findings from CALGB 89803/Alliance..” Clin Colorectal Cancer 12, no. 4 (December 2013): 233–38. https://doi.org/10.1016/j.clcc.2013.06.005.
       Full Text  Link to Item
    • Morse, Michael A., Donna Niedzwiecki, John L. Marshall, Christopher Garrett, David Z. Chang, Mebea Aklilu, Todd S. Crocenzi, et al. “A randomized phase II study of immunization with dendritic cells modified with poxvectors encoding CEA and MUC1 compared with the same poxvectors plus GM-CSF for resected metastatic colorectal cancer..” Ann Surg 258, no. 6 (December 2013): 879–86. https://doi.org/10.1097/SLA.0b013e318292919e.
       Full Text  Link to Item
    • Warren, Robert S., Chloe E. Atreya, Donna Niedzwiecki, Vivian K. Weinberg, David B. Donner, Robert J. Mayer, Richard M. Goldberg, et al. “Association of TP53 mutational status and gender with survival after adjuvant treatment for stage III colon cancer: results of CALGB 89803..” Clin Cancer Res 19, no. 20 (October 15, 2013): 5777–87. https://doi.org/10.1158/1078-0432.CCR-13-0351.
       Full Text  Link to Item
    • Ronellenfitsch, Ulrich, Matthias Schwarzbach, Ralf Hofheinz, Peter Kienle, Meinhard Kieser, Tracy E. Slanger, Bryan Burmeister, et al. “Preoperative chemo(radio)therapy versus primary surgery for gastroesophageal adenocarcinoma: systematic review with meta-analysis combining individual patient and aggregate data..” Eur J Cancer 49, no. 15 (October 2013): 3149–58. https://doi.org/10.1016/j.ejca.2013.05.029.
       Full Text  Link to Item
    • Van Loon, Katherine, Devin Wigler, Donna Niedzwiecki, Alan P. Venook, Charles Fuchs, Charles Blanke, Leonard Saltz, Richard M. Goldberg, and Jeffrey A. Meyerhardt. “Comparison of dietary and lifestyle habits among stage III and metastatic colorectal cancer patients: findings from CALGB 89803 and CALGB 80405..” Clin Colorectal Cancer 12, no. 2 (June 2013): 95–102. https://doi.org/10.1016/j.clcc.2012.11.002.
       Full Text  Link to Item
    • Ronellenfitsch, Ulrich, Matthias Schwarzbach, Ralf Hofheinz, Peter Kienle, Meinhard Kieser, Tracy E. Slanger, Katrin Jensen, and Katrin GE Adenocarcinoma Meta‐analysis Group. “Perioperative chemo(radio)therapy versus primary surgery for resectable adenocarcinoma of the stomach, gastroesophageal junction, and lower esophagus..” Cochrane Database Syst Rev, no. 5 (May 31, 2013). https://doi.org/10.1002/14651858.CD008107.pub2.
       Full Text  Link to Item
    • Venook, Alan P., Donna Niedzwiecki, Margarita Lopatin, Xing Ye, Mark Lee, Paula N. Friedman, Wendy Frankel, et al. “Biologic determinants of tumor recurrence in stage II colon cancer: validation study of the 12-gene recurrence score in cancer and leukemia group B (CALGB) 9581..” J Clin Oncol 31, no. 14 (May 10, 2013): 1775–81. https://doi.org/10.1200/JCO.2012.45.1096.
       Full Text  Link to Item
    • Gajewski, Thomas F., April K. S. Salama, Donna Niedzwiecki, Jeffrey Johnson, Gerald Linette, Cynthia Bucher, Michelle A. Blaskovich, Said M. Sebti, Frank Haluska, and Frank Cancer and Leukemia Group B. “Phase II study of the farnesyltransferase inhibitor R115777 in advanced melanoma (CALGB 500104)..” J Transl Med 10 (December 10, 2012). https://doi.org/10.1186/1479-5876-10-246.
       Full Text  Link to Item
    • Meyerhardt, Jeffrey A., Kaori Sato, Donna Niedzwiecki, Cynthia Ye, Leonard B. Saltz, Robert J. Mayer, Rex B. Mowat, et al. “Dietary glycemic load and cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803..” J Natl Cancer Inst 104, no. 22 (November 21, 2012): 1702–11. https://doi.org/10.1093/jnci/djs399.
       Full Text  Link to Item
    • Kanda, Junya, Lun-Wei Chiou, Paul Szabolcs, Gregory D. Sempowski, David A. Rizzieri, Gwynn D. Long, Keith M. Sullivan, et al. “Immune recovery in adult patients after myeloablative dual umbilical cord blood, matched sibling, and matched unrelated donor hematopoietic cell transplantation..” Biol Blood Marrow Transplant 18, no. 11 (November 2012): 1664-1676.e1. https://doi.org/10.1016/j.bbmt.2012.06.005.
       Full Text  Link to Item
    • Osada, Takuya, Peter Berglund, Michael A. Morse, Bolyn Hubby, Whitney Lewis, Donna Niedzwiecki, Xiao Yi Yang, et al. “Co-delivery of antigen and IL-12 by Venezuelan equine encephalitis virus replicon particles enhances antigen-specific immune responses and antitumor effects..” Cancer Immunol Immunother 61, no. 11 (November 2012): 1941–51. https://doi.org/10.1007/s00262-012-1248-y.
       Full Text  Link to Item
    • Hasson, Rian M., Donna Niedzwiecki, and Monica M. Bertagnolli. “Abstract 4514: A comparison of two methodologies to quantify Thymidylate synthase for predicting survival in patients with colorectal cancer treated on CALGB 89803.” Clinical Research, April 15, 2012. https://doi.org/10.1158/1538-7445.am2012-4514.
       Full Text
    • Atreya, C. E., R. S. Warren, D. Niedzwiecki, R. J. Mayer, R. M. Goldberg, C. C. Compton, M. Zuraek, et al. “A novel interaction of genotype, gender, and adjuvant treatment in survival after resection of stage III colon cancer: Results of CALGB 89803..” J Clin Oncol 30, no. 4_suppl (February 2012).
       Link to Item
    • Romanus, Dorothy, Hedy L. Kindler, Laura Archer, Ethan Basch, Donna Niedzwiecki, Jane Weeks, Deborah Schrag, and Deborah Cancer and Leukemia Group B. “Does health-related quality of life improve for advanced pancreatic cancer patients who respond to gemcitabine? Analysis of a randomized phase III trial of the cancer and leukemia group B (CALGB 80303)..” J Pain Symptom Manage 43, no. 2 (February 2012): 205–17. https://doi.org/10.1016/j.jpainsymman.2011.09.001.
       Full Text  Link to Item
    • Ng, Kimmie, Shuji Ogino, Jeffrey A. Meyerhardt, Jennifer A. Chan, Andrew T. Chan, Donna Niedzwiecki, Donna Hollis, et al. “Relationship between statin use and colon cancer recurrence and survival: results from CALGB 89803..” J Natl Cancer Inst 103, no. 20 (October 19, 2011): 1540–51. https://doi.org/10.1093/jnci/djr307.
       Full Text  Link to Item
    • Bertagnolli, Monica M., Mark Redston, Carolyn C. Compton, Donna Niedzwiecki, Robert J. Mayer, Richard M. Goldberg, Thomas A. Colacchio, Leonard B. Saltz, and Robert S. Warren. “Microsatellite instability and loss of heterozygosity at chromosomal location 18q: prospective evaluation of biomarkers for stages II and III colon cancer--a study of CALGB 9581 and 89803..” J Clin Oncol 29, no. 23 (August 10, 2011): 3153–62. https://doi.org/10.1200/JCO.2010.33.0092.
       Full Text  Link to Item
    • Niedzwiecki, Donna, Monica M. Bertagnolli, Robert S. Warren, Carolyn C. Compton, Nancy E. Kemeny, Al Bowen Benson, S Gail Eckhardt, et al. “Documenting the natural history of patients with resected stage II adenocarcinoma of the colon after random assignment to adjuvant treatment with edrecolomab or observation: results from CALGB 9581..” J Clin Oncol 29, no. 23 (August 10, 2011): 3146–52. https://doi.org/10.1200/JCO.2010.32.5357.
       Full Text  Link to Item
    • Mamon, Harvey J., Donna Niedzwiecki, Donna Hollis, Benjamin R. Tan, Robert J. Mayer, Joel E. Tepper, Richard M. Goldberg, A William Blackstock, Charles S. Fuchs, and Charles S. Cancer and Leukemia Group B. “A phase 2 trial of gemcitabine, 5-fluorouracil, and radiation therapy in locally advanced nonmetastatic pancreatic adenocarcinoma : cancer and Leukemia Group B (CALGB) 80003..” Cancer 117, no. 12 (June 15, 2011): 2620–28. https://doi.org/10.1002/cncr.25742.
       Full Text  Link to Item
    • Kanda, Junya, David A. Rizzieri, Cristina Gasparetto, Gwynn D. Long, John P. Chute, Keith M. Sullivan, Ashley Morris, et al. “Adult dual umbilical cord blood transplantation using myeloablative total body irradiation (1350 cGy) and fludarabine conditioning..” Biol Blood Marrow Transplant 17, no. 6 (June 2011): 867–74. https://doi.org/10.1016/j.bbmt.2010.09.009.
       Full Text  Link to Item
    • Fuchs, C. S., J. E. Tepper, D. Niedzwiecki, D. Hollis, H. J. Mamon, R. Swanson, D. G. Haller, et al. “Postoperative adjuvant chemoradiation for gastric or gastroesophageal junction (GEJ) adenocarcinoma using epirubicin, cisplatin, and infusional (CI) 5-FU (ECF) before and after CI 5-FU and radiotherapy (CRT) compared with bolus 5-FU/LV before and after CRT: Intergroup trial CALGB 80101..” Journal of Clinical Oncology 29, no. 15_suppl (May 20, 2011): 4003–4003. https://doi.org/10.1200/jco.2011.29.15_suppl.4003.
       Full Text
    • Fuchs, C. S., J. E. Tepper, D. Niedzwiecki, D. Hollis, H. J. Mamon, R. Swanson, D. G. Haller, et al. “Postoperative adjuvant chemoradiation for gastric or gastroesophageal junction (GEJ) adenocarcinoma using epirubicin, cisplatin, and infusional (CI) 5-FU (ECF) before and after CI 5-FU and radiotherapy (CRT) compared with bolus 5-FU/LV before and after CRT: Intergroup trial CALGB 80101..” J Clin Oncol 29, no. 15_suppl (May 20, 2011).
       Link to Item
    • Lyerly, H. K., A. Hobeika, D. Niedzwiecki, T. Osada, J. Marshall, C. R. Garrett, D. Z. Chang, et al. “A dendritic cell-based vaccine effects on T-cell responses compared with a viral vector vaccine when administered to patients following resection of colorectal metastases in a randomized phase II study..” J Clin Oncol 29, no. 15_suppl (May 20, 2011).
       Link to Item
    • Morse, M., D. Niedzwiecki, J. Marshall, C. R. Garrett, D. Z. Chang, M. Aklilu, T. S. Crocenzi, et al. “Survival rates among patients vaccinated following resection of colorectal cancer metastases in a phase II randomized study compared with contemporary controls..” J Clin Oncol 29, no. 15_suppl (May 20, 2011).
       Link to Item
    • Van Loon, K., D. Wigler, D. Niedzwiecki, D. Hollis, A. P. Venook, C. D. Blanke, L. Saltz, R. M. Goldberg, C. S. Fuchs, and J. A. Meyerhardt. “A comparison of dietary and lifestyle habits among stage III and metastatic colorectal cancer patients..” Journal of Clinical Oncology 29, no. 15_suppl (May 20, 2011): e14026–e14026. https://doi.org/10.1200/jco.2011.29.15_suppl.e14026.
       Full Text
    • Van Loon, K., D. Wigler, D. Niedzwiecki, D. Hollis, A. P. Venook, C. D. Blanke, L. Saltz, R. M. Goldberg, C. S. Fuchs, and J. A. Meyerhardt. “A comparison of dietary and lifestyle habits among stage III and metastatic colorectal cancer patients..” J Clin Oncol 29, no. 15_suppl (May 20, 2011).
       Link to Item
    • Venook, A. P., D. Niedzwiecki, M. Lopatin, M. Lee, P. N. Friedman, W. Frankel, K. Clark-Langone, et al. “Validation of a 12-gene colon cancer recurrence score (RS) in patients (pts) with stage II colon cancer (CC) from CALGB 9581.” Journal of Clinical Oncology 29, no. 15 (May 20, 2011).
       Link to Item
    • Venook, A. P., D. Niedzwiecki, M. Lopatin, M. Lee, P. N. Friedman, W. Frankel, K. Clark-Langone, et al. “Validation of a 12-gene colon cancer recurrence score (RS) in patients (pts) with stage II colon cancer (CC) from CALGB 9581..” J Clin Oncol 29, no. 15_suppl (May 20, 2011).
       Link to Item
    • Kaiser, Lee D., Allen S. Melemed, Alaknanda J. Preston, Hilary A. Chaudri Ross, Donna Niedzwiecki, Gwendolyn A. Fyfe, Jacqueline M. Gough, et al. “Optimizing collection of adverse event data in cancer clinical trials supporting supplemental indications..” J Clin Oncol 28, no. 34 (December 1, 2010): 5046–53. https://doi.org/10.1200/JCO.2010.29.6608.
       Full Text  Link to Item
    • Ng, Kimmie, Jeffrey A. Meyerhardt, Jennifer A. Chan, Donna Niedzwiecki, Donna R. Hollis, Leonard B. Saltz, Robert J. Mayer, et al. “Multivitamin use is not associated with cancer recurrence or survival in patients with stage III colon cancer: findings from CALGB 89803..” J Clin Oncol 28, no. 28 (October 1, 2010): 4354–63. https://doi.org/10.1200/JCO.2010.28.0362.
       Full Text  Link to Item
    • Morse, Michael A., Amy C. Hobeika, Takuya Osada, Peter Berglund, Bolyn Hubby, Sarah Negri, Donna Niedzwiecki, et al. “An alphavirus vector overcomes the presence of neutralizing antibodies and elevated numbers of Tregs to induce immune responses in humans with advanced cancer..” J Clin Invest 120, no. 9 (September 2010): 3234–41. https://doi.org/10.1172/JCI42672.
       Full Text  Open Access Copy  Link to Item
    • Kindler, Hedy Lee, Donna Niedzwiecki, Donna Hollis, Susan Sutherland, Deborah Schrag, Herbert Hurwitz, Federico Innocenti, et al. “Gemcitabine plus bevacizumab compared with gemcitabine plus placebo in patients with advanced pancreatic cancer: phase III trial of the Cancer and Leukemia Group B (CALGB 80303)..” J Clin Oncol 28, no. 22 (August 1, 2010): 3617–22. https://doi.org/10.1200/JCO.2010.28.1386.
       Full Text  Link to Item
    • Crout, Christopher A., Liang-Piu Koh, Jon P. Gockerman, Joseph O. Moore, Carlos Decastro, Gwynn D. Long, Louis Diehl, et al. “Overcoming drug resistance in mantle cell lymphoma using a combination of dose-dense and intense therapy..” Cancer Invest 28, no. 6 (July 2010): 654–60. https://doi.org/10.3109/07357901003631015.
       Full Text  Link to Item
    • Enzinger, P. C., B. Burtness, D. Hollis, D. Niedzwiecki, D. Ilson, A. B. Benson, R. J. Mayer, and R. M. Goldberg. “A randomized phase II study of three standard chemotherapy regimens (ECF, IC, FOLFOX) plus cetuximab in metastatic esophageal and GE junction cancer.” Journal of Clinical Oncology 28, no. 15 (May 20, 2010).
       Link to Item
    • McCleary, Nadine Jackson, Donna Niedzwiecki, Donna Hollis, Leonard B. Saltz, Paul Schaefer, Renaud Whittom, Alexander Hantel, Al Benson, Richard Goldberg, and Jeffrey A. Meyerhardt. “Impact of smoking on patients with stage III colon cancer: results from Cancer and Leukemia Group B 89803..” Cancer 116, no. 4 (February 15, 2010): 957–66. https://doi.org/10.1002/cncr.24866.
       Full Text  Link to Item
    • O’Reilly, Eileen M., Donna Niedzwiecki, Margaret Hall, Donna Hollis, Tanios Bekaii-Saab, Timothy Pluard, Kathe Douglas, et al. “A Cancer and Leukemia Group B phase II study of sunitinib malate in patients with previously treated metastatic pancreatic adenocarcinoma (CALGB 80603)..” Oncologist 15, no. 12 (2010): 1310–19. https://doi.org/10.1634/theoncologist.2010-0152.
       Full Text  Link to Item
    • Damon, Lloyd E., Jeffrey L. Johnson, Donna Niedzwiecki, Bruce D. Cheson, David D. Hurd, Nancy L. Bartlett, Ann S. Lacasce, et al. “Immunochemotherapy and autologous stem-cell transplantation for untreated patients with mantle-cell lymphoma: CALGB 59909..” J Clin Oncol 27, no. 36 (December 20, 2009): 6101–8. https://doi.org/10.1200/JCO.2009.22.2554.
       Full Text  Link to Item
    • Canellos, George P., Donna Niedzwiecki, and Jeffrey L. Johnson. “Long-term follow-up of survival in Hodgkin's lymphoma..” N Engl J Med 361, no. 24 (December 10, 2009): 2390–91. https://doi.org/10.1056/NEJMc0906731.
       Full Text  Link to Item
    • Ogino, Shuji, Jeffrey A. Meyerhardt, Natsumi Irahara, Donna Niedzwiecki, Donna Hollis, Leonard B. Saltz, Robert J. Mayer, et al. “KRAS mutation in stage III colon cancer and clinical outcome following intergroup trial CALGB 89803..” Clin Cancer Res 15, no. 23 (December 1, 2009): 7322–29. https://doi.org/10.1158/1078-0432.CCR-09-1570.
       Full Text  Link to Item
    • Kulke, Matthew H., Margaret A. Tempero, Donna Niedzwiecki, Donna R. Hollis, Hedy L. Kindler, Michael Cusnir, Peter C. Enzinger, Stefan M. Gorsch, Richard M. Goldberg, and Robert J. Mayer. “Randomized phase II study of gemcitabine administered at a fixed dose rate or in combination with cisplatin, docetaxel, or irinotecan in patients with metastatic pancreatic cancer: CALGB 89904..” J Clin Oncol 27, no. 33 (November 20, 2009): 5506–12. https://doi.org/10.1200/JCO.2009.22.1309.
       Full Text  Link to Item
    • Osada, T., X. Y. Yang, Z. C. Hartman, O. Glass, B. L. Hodges, D. Niedzwiecki, M. A. Morse, H. K. Lyerly, A. Amalfitano, and T. M. Clay. “Optimization of vaccine responses with an E1, E2b and E3-deleted Ad5 vector circumvents pre-existing anti-vector immunity..” Cancer Gene Ther 16, no. 9 (September 2009): 673–82. https://doi.org/10.1038/cgt.2009.17.
       Full Text  Link to Item
    • Posner, M. C., D. Niedzwiecki, A. P. Venook, D. R. Hollis, H. L. Kindler, E. W. Martin, R. L. Schilsky, R. M. Goldberg, and R. J. Mayer. “Erratum: A phase II prospective multi-institutional trial of adjuvant active specific immunotherapy following curative resection of colorectal cancer hepatic metastases: Cancer and leukemia group B study 89903 (Annals of Surgical Oncology (2008) 15 (158-164) DOI: 10.1245/S10434-007-9654-7).” Annals of Surgical Oncology 16, no. 8 (August 1, 2009). https://doi.org/10.1245/s10434-009-0466-9.
       Full Text
    • Bertagnolli, M. M., D. Niedzwiecki, M. Hall, S. D. Jewell, R. J. Mayer, R. M. Goldberg, T. A. Colacchio, R. S. Warren, and M. Redston. “Presence of 18q loss of heterozygosity (LOH) and disease-free and overall survival in stage II colon cancer: CALGB Protocol 9581..” J Clin Oncol 27, no. 15_suppl (May 20, 2009).
       Link to Item
    • Fuchs, C., S. Ogino, J. A. Meyerhardt, N. Irahara, D. Niedzwiecki, D. Hollis, L. B. Saltz, R. J. Mayer, and M. M. Bertagnolli. “KRAS mutation, cancer recurrence, and patient survival in stage III colon cancer: Findings from CALGB 89803..” J Clin Oncol 27, no. 15_suppl (May 20, 2009).
       Link to Item
    • Osada, Takuya, Christopher Y. Woo, Matthew McKinney, Xiao Yi Yang, Gangjun Lei, Heather G. Labreche, Zachary C. Hartman, et al. “Induction of Wilms' tumor protein (WT1)-specific antitumor immunity using a truncated WT1-expressing adenovirus vaccine..” Clin Cancer Res 15, no. 8 (April 15, 2009): 2789–96. https://doi.org/10.1158/1078-0432.CCR-08-2589.
       Full Text  Link to Item
    • Bertagnolli, Monica M., Donna Niedzwiecki, Carolyn C. Compton, Hejin P. Hahn, Margaret Hall, Beatrice Damas, Scott D. Jewell, et al. “Microsatellite instability predicts improved response to adjuvant therapy with irinotecan, fluorouracil, and leucovorin in stage III colon cancer: Cancer and Leukemia Group B Protocol 89803..” J Clin Oncol 27, no. 11 (April 10, 2009): 1814–21. https://doi.org/10.1200/JCO.2008.18.2071.
       Full Text  Link to Item
    • Bertagnolli, Monica M., Robert S. Warren, Donna Niedzwiecki, Elke Mueller, Carolyn C. Compton, Mark Redston, Margaret Hall, et al. “p27Kip1 in stage III colon cancer: implications for outcome following adjuvant chemotherapy in cancer and leukemia group B protocol 89803..” Clin Cancer Res 15, no. 6 (March 15, 2009): 2116–22. https://doi.org/10.1158/1078-0432.CCR-08-2674.
       Full Text  Link to Item
    • Reddy, Srinevas K., Gloria Broadwater, Donna Niedzwiecki, Andrew S. Barbas, Herbert I. Hurwitz, Johanna C. Bendell, Michael A. Morse, and Bryan M. Clary. “Multiagent chemotherapy for isolated colorectal liver metastases: a single-centered retrospective study..” J Gastrointest Surg 13, no. 1 (January 2009): 74–84. https://doi.org/10.1007/s11605-008-0617-5.
       Full Text  Link to Item
    • Tepper, J. E., and D. Niedzwiecki. “In reply.” Journal of Clinical Oncology 26, no. 31 (November 1, 2008). https://doi.org/10.1200/JCO.2008.19.0678.
       Full Text
    • Meyerhardt, Jeffrey A., Donna Niedzwiecki, Donna Hollis, Leonard B. Saltz, Robert J. Mayer, Heidi Nelson, Renaud Whittom, et al. “Impact of body mass index and weight change after treatment on cancer recurrence and survival in patients with stage III colon cancer: findings from Cancer and Leukemia Group B 89803..” J Clin Oncol 26, no. 25 (September 1, 2008): 4109–15. https://doi.org/10.1200/JCO.2007.15.6687.
       Full Text  Link to Item
    • Morse, Michael A., Amy C. Hobeika, Takuya Osada, Delila Serra, Donna Niedzwiecki, H Kim Lyerly, and Timothy M. Clay. “Depletion of human regulatory T cells specifically enhances antigen-specific immune responses to cancer vaccines..” Blood 112, no. 3 (August 1, 2008): 610–18. https://doi.org/10.1182/blood-2008-01-135319.
       Full Text  Link to Item
    • Meropol, Neal J., Donna Niedzwiecki, Brenda Shank, Thomas A. Colacchio, John Ellerton, Frank Valone, Susan Budinger, et al. “Induction therapy for poor-prognosis anal canal carcinoma: a phase II study of the cancer and Leukemia Group B (CALGB 9281)..” Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 26, no. 19 (July 2008): 3229–34. https://doi.org/10.1200/jco.2008.16.2339.
       Full Text
    • Chan, Jennifer A., Jeffrey A. Meyerhardt, Donna Niedzwiecki, Donna Hollis, Leonard B. Saltz, Robert J. Mayer, James Thomas, et al. “Association of family history with cancer recurrence and survival among patients with stage III colon cancer..” Jama 299, no. 21 (June 4, 2008): 2515–23. https://doi.org/10.1001/jama.299.21.2515.
       Full Text  Link to Item
    • Clay, T. M., A. Hobeika, T. Osada, D. Serra, D. Niedzwiecki, H. K. Lyerly, and M. A. Morse. “Depletion of human regulatory T cells (Treg) and antigen-specific immune responses to cancer vaccines..” J Clin Oncol 26, no. 15_suppl (May 20, 2008).
       Link to Item
    • Jackson, N. A., C. S. Fuchs, D. Niedzwiecki, D. R. Hollis, L. B. Saltz, R. J. Mayer, and J. A. Meyerhardt. “The impact of smoking on cancer recurrence and survival in patients with stage III colon cancer: Findings from intergroup trial CALGB 89803.” Journal of Clinical Oncology 26, no. 15_suppl (May 20, 2008): 4039–4039. https://doi.org/10.1200/jco.2008.26.15_suppl.4039.
       Full Text
    • Jackson, N. A., C. S. Fuchs, D. Niedzwiecki, D. R. Hollis, L. B. Saltz, R. J. Mayer, and J. A. Meyerhardt. “The impact of smoking on cancer recurrence and survival in patients with stage III colon cancer: Findings from intergroup trial CALGB 89803..” J Clin Oncol 26, no. 15_suppl (May 20, 2008).
       Link to Item
    • Ocean, A. J., D. Niedzwiecki, J. N. Atkins, B. Parker, B. H. O’Neil, J. W. Lee, S. Wadler, and R. M. Goldberg. “LE-SN38 for metastatic colorectal cancer after progression on oxaliplatin: Results of CALGB 80402..” J Clin Oncol 26, no. 15_suppl (May 20, 2008).
       Link to Item
    • Ocean, A. J., D. Niedzwiecki, J. N. Atkins, B. Parker, B. H. O’Neil, J. W. Lee, S. Wadler, and R. M. Goldberg. “LE-SN38 for metastatic colorectal cancer after progression on oxaliplatin: Results of CALGB 80402.” Journal of Clinical Oncology 26, no. 15_suppl (May 20, 2008): 4109–4109. https://doi.org/10.1200/jco.2008.26.15_suppl.4109.
       Full Text
    • O’Reilly, E. M., D. Niedzwiecki, D. R. Hollis, T. S. Bekaii-Saab, T. Pluard, A. Duffy, F. Overcash, S. P. Ivy, and R. M. Goldberg. “A phase II trial of sunitinib (S) in previously-treated pancreas adenocarcinoma (PAC), CALGB 80603..” J Clin Oncol 26, no. 15_suppl (May 20, 2008).
       Link to Item
    • O’Reilly, E. M., D. Niedzwiecki, D. R. Hollis, T. S. Bekaii-Saab, T. Pluard, A. Duffy, F. Overcash, S. P. Ivy, and R. M. Goldberg. “A phase II trial of sunitinib (S) in previously-treated pancreas adenocarcinoma (PAC), CALGB 80603.” Journal of Clinical Oncology 26, no. 15 (May 20, 2008).
       Link to Item
    • Tepper, Joel, Mark J. Krasna, Donna Niedzwiecki, Donna Hollis, Carolyn E. Reed, Richard Goldberg, Krystyna Kiel, Christopher Willett, David Sugarbaker, and Robert Mayer. “Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781..” J Clin Oncol 26, no. 7 (March 1, 2008): 1086–92. https://doi.org/10.1200/JCO.2007.12.9593.
       Full Text  Link to Item
    • Korn, Edward L., Ping-Yu Liu, Sandra J. Lee, Judith-Anne W. Chapman, Donna Niedzwiecki, Vera J. Suman, James Moon, et al. “Meta-analysis of phase II cooperative group trials in metastatic stage IV melanoma to determine progression-free and overall survival benchmarks for future phase II trials..” J Clin Oncol 26, no. 4 (February 1, 2008): 527–34. https://doi.org/10.1200/JCO.2007.12.7837.
       Full Text  Link to Item
    • Meyerhardt, J. A., D. Niedzwiecki, D. Hollis, L. B. Saltz, F. B. Hu, R. J. Mayer, H. Nelson, et al. “Association of dietary patterns with cancer recurrence and survival in patients with stage III colon cancer.” Obstetrical and Gynecological Survey 63, no. 2 (February 1, 2008): 94–96. https://doi.org/10.1097/01.ogx.0000300472.76442.c2.
       Full Text
    • Smith, Sonali M., David Grinblatt, Jeffrey L. Johnson, Donna Niedzwiecki, David Rizzieri, Nancy L. Bartlett, Bruce D. Cheson, and Bruce D. Cancer and Leukemia Group B. “Thalidomide has limited single-agent activity in relapsed or refractory indolent non-Hodgkin lymphomas: a phase II trial of the Cancer and Leukemia Group B..” Br J Haematol 140, no. 3 (February 2008): 313–19. https://doi.org/10.1111/j.1365-2141.2007.06937.x.
       Full Text  Link to Item
    • Hobeika, Ac, T. Osada, D. Serra, S. Peplinski, K. Hanson, Y. Tanaka, D. Niedzwiecki, et al. “Detailed analysis of cytomegalovirus (CMV)-specific T cells expanded for adoptive immunotherapy of CMV infection following allogeneic stem cell transplantation for malignant disease..” Cytotherapy 10, no. 3 (2008): 289–302. https://doi.org/10.1080/14653240801927040.
       Full Text  Link to Item
    • Posner, Mitchell C., Donna Niedzwiecki, Alan P. Venook, Donna R. Hollis, Hedy L. Kindler, Edward W. Martin, Richard L. Schilsky, Richard M. Goldberg, and Robert J. Mayer. “A phase II prospective multi-institutional trial of adjuvant active specific immunotherapy following curative resection of colorectal cancer hepatic metastases: cancer and leukemia group B study 89903..” Ann Surg Oncol 15, no. 1 (January 2008): 158–64. https://doi.org/10.1245/s10434-007-9654-7.
       Full Text  Link to Item
    • Morse, Michael A., Amy Hobeika, Takuya Osada, Donna Niedzwiecki, Paul Kelly Marcom, Kimberly L. Blackwell, Carey Anders, Gayathri R. Devi, H Kim Lyerly, and Timothy M. Clay. “Long term disease-free survival and T cell and antibody responses in women with high-risk Her2+ breast cancer following vaccination against Her2..” J Transl Med 5 (September 6, 2007). https://doi.org/10.1186/1479-5876-5-42.
       Full Text  Link to Item
    • Meyerhardt, Jeffrey A., Donna Niedzwiecki, Donna Hollis, Leonard B. Saltz, Frank B. Hu, Robert J. Mayer, Heidi Nelson, et al. “Association of dietary patterns with cancer recurrence and survival in patients with stage III colon cancer..” Jama 298, no. 7 (August 15, 2007): 754–64. https://doi.org/10.1001/jama.298.7.754.
       Full Text  Link to Item
    • Saltz, Leonard B., Donna Niedzwiecki, Donna Hollis, Richard M. Goldberg, Alexander Hantel, James P. Thomas, Anthony L. A. Fields, and Robert J. Mayer. “Irinotecan fluorouracil plus leucovorin is not superior to fluorouracil plus leucovorin alone as adjuvant treatment for stage III colon cancer: results of CALGB 89803..” J Clin Oncol 25, no. 23 (August 10, 2007): 3456–61. https://doi.org/10.1200/JCO.2007.11.2144.
       Full Text  Link to Item
    • Blum, Kristie A., Jeffrey L. Johnson, Donna Niedzwiecki, George P. Canellos, Bruce D. Cheson, and Nancy L. Bartlett. “Single agent bortezomib in the treatment of relapsed and refractory Hodgkin lymphoma: cancer and leukemia Group B protocol 50206..” Leuk Lymphoma 48, no. 7 (July 2007): 1313–19. https://doi.org/10.1080/10428190701411458.
       Full Text  Link to Item
    • Bartlett, N. L., D. Niedzwiecki, J. L. Johnson, J. W. Friedberg, K. B. Johnson, K. van Besien, A. D. Zelenetz, B. D. Cheson, G. P. Canellos, and G. P. Cancer Leukemia Group B. “Gemcitabine, vinorelbine, and pegylated liposomal doxorubicin (GVD), a salvage regimen in relapsed Hodgkin's lymphoma: CALGB 59804..” Ann Oncol 18, no. 6 (June 2007): 1071–79. https://doi.org/10.1093/annonc/mdm090.
       Full Text  Link to Item
    • Venook, Alan P., Charles D. Blanke, Donna Niedzwiecki, Heinz-Josef Lenz, John R. Taylor, Donna R. Hollis, Susan Sutherland, and Richard M. Goldberg. “Revisiting the Cancer and Leukemia Group B/Southwest Oncology Group 80405 Trial: a phase III trial of chemotherapy and biologic agents for patients with untreated advanced colorectal adenocarcinoma..” Clin Colorectal Cancer 6, no. 7 (May 2007): 536–38. https://doi.org/10.3816/CCC.2007.n.021.
       Full Text  Link to Item
    • Rizzieri, David A., Liang Piu Koh, Gwynn D. Long, Cristina Gasparetto, Keith M. Sullivan, Mitchell Horwitz, John Chute, et al. “Partially matched, nonmyeloablative allogeneic transplantation: clinical outcomes and immune reconstitution..” J Clin Oncol 25, no. 6 (February 20, 2007): 690–97. https://doi.org/10.1200/JCO.2006.07.0953.
       Full Text  Link to Item
    • Ryan, David P., Donna Niedzwiecki, Donna Hollis, Joel Tepper, and Robert J. Mayer. “In Reply.” Journal of Clinical Oncology 25, no. 5 (February 10, 2007): 603–603. https://doi.org/10.1200/jco.2006.09.4805.
       Full Text
    • Czuczman, Myron S., Pierluigi Porcu, Jeffrey Johnson, Donna Niedzwiecki, Michael Kelly, Eric D. Hsi, James R. Cook, George Canellos, Bruce D. Cheson, and Bruce D. Cancer and Leukemia Group B. “Results of a phase II study of 506U78 in cutaneous T-cell lymphoma and peripheral T-cell lymphoma: CALGB 59901..” Leuk Lymphoma 48, no. 1 (January 2007): 97–103. https://doi.org/10.1080/10428190600961058.
       Full Text  Link to Item
    • Goel, Ajay, Takeshi Nagasaka, Christian N. Arnold, Toru Inoue, Cody Hamilton, Donna Niedzwiecki, Carolyn Compton, et al. “The CpG island methylator phenotype and chromosomal instability are inversely correlated in sporadic colorectal cancer..” Gastroenterology 132, no. 1 (January 2007): 127–38. https://doi.org/10.1053/j.gastro.2006.09.018.
       Full Text  Link to Item
    • Szabolcs, P., and D. Niedzwiecki. “Immune reconstitution after unrelated cord blood transplantation..” Cytotherapy 9, no. 2 (2007): 111–22. https://doi.org/10.1080/14653240701231014.
       Full Text  Link to Item
    • Blum, Kristie A., Jeffrey L. Johnson, Donna Niedzwiecki, Lawrence D. Piro, Alan Saven, Bruce A. Peterson, John C. Byrd, Bruce D. Cheson, and Bruce D. Cancer and Leukemia Group B Study 9153. “Prolonged follow-up after initial therapy with 2-chlorodeoxyadenosine in patients with indolent non-Hodgkin lymphoma: results of Cancer and Leukemia Group B Study 9153..” Cancer 107, no. 12 (December 15, 2006): 2817–25. https://doi.org/10.1002/cncr.22344.
       Full Text  Link to Item
    • Franklin, J., A. Pluetschow, M. Paus, L. Specht, A. -. P. Anselmo, A. Aviles, G. Biti, et al. “Second malignancy risk associated with treatment of Hodgkin's lymphoma: meta-analysis of the randomised trials..” Ann Oncol 17, no. 12 (December 2006): 1749–60. https://doi.org/10.1093/annonc/mdl302.
       Full Text  Link to Item
    • Krown, Susan E., Donna Niedzwiecki, Wen-Jen Hwu, Lydia Hodgson, Alan N. Houghton, Frank G. Haluska, and Frank G. Cancer and Leukemia Group B. “Phase II study of temozolomide and thalidomide in patients with metastatic melanoma in the brain: high rate of thromboembolic events (CALGB 500102)..” Cancer 107, no. 8 (October 15, 2006): 1883–90. https://doi.org/10.1002/cncr.22239.
       Full Text  Link to Item
    • Bosworth, Hayden B., Don C. Rockey, Erik K. Paulson, Donna Niedzwiecki, Wendy Davis, Linda L. Sanders, Judy Yee, et al. “Prospective comparison of patient experience with colon imaging tests..” Am J Med 119, no. 9 (September 2006): 791–99. https://doi.org/10.1016/j.amjmed.2006.02.013.
       Full Text  Link to Item
    • Thompson, William M., William L. Foster, Erik K. Paulson, Donna Niedzwiecki, Vincent H. S. Low, Lori B. Fulford, Bob W. Broomer, Linda Sanders, and Don C. Rockey. “Comparison of radiologists and technologists in the performance of air-contrast barium enemas..” Ajr Am J Roentgenol 187, no. 3 (September 2006): 706–9. https://doi.org/10.2214/AJR.05.0526.
       Full Text  Link to Item
    • Meyerhardt, Jeffrey A., Denise Heseltine, Donna Niedzwiecki, Donna Hollis, Leonard B. Saltz, Robert J. Mayer, James Thomas, et al. “Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803..” J Clin Oncol 24, no. 22 (August 1, 2006): 3535–41. https://doi.org/10.1200/JCO.2006.06.0863.
       Full Text  Link to Item
    • Smith, Sonali M., Jeffrey L. Johnson, Donna Niedzwiecki, J Paul Eder, George Canellos, Bruce D. Cheson, Nancy L. Bartlett, and Nancy L. Cancer and Leukemia Group B. “Sequential doxorubicin and topotecan in relapsed/refractory aggressive non-Hodgkin's lymphoma: results of CALGB 59906..” Leuk Lymphoma 47, no. 8 (August 2006): 1511–17. https://doi.org/10.1080/10428190600581385.
       Full Text  Link to Item
    • Bertagnolli, M. M., C. C. Compton, D. Niedzwiecki, R. S. Warren, S. Jewell, G. P. Bailey, R. J. Mayer, R. Goldberg, L. Saltz, and M. Redston. “Microsatellite instability predicts improved response to adjuvant therapy with irinotecan, 5-fluorouracil and leucovorin in stage III colon cancer..” J Clin Oncol 24, no. 18_suppl (June 20, 2006).
       Link to Item
    • Blum, K. A., J. L. Johnson, D. Niedzwiecki, G. P. Cannellos, B. D. Cheson, and N. L. Bartlett. “A phase II study of bortezomib in relapsed Hodgkin lymphoma: Preliminary results of CALGB 50206..” J Clin Oncol 24, no. 18_suppl (June 20, 2006).
       Link to Item
    • Gajewski, T. F., D. Niedzwiecki, J. Johnson, G. Linette, C. Bucher, M. Blaskovich, S. Sebti, and F. Haluska. “Phase II study of the farnesyltransferase inhibitor R115777 in advanced melanoma: CALGB 500104..” J Clin Oncol 24, no. 18_suppl (June 20, 2006).
       Link to Item
    • Tepper, J. E., M. Krasna, D. Niedzwiecki, D. Hollis, C. Reed, R. Goldberg, T. Rich, K. Kiel, and R. Mayer. “Superiority of trimodality therapy to surgery alone in esophageal cancer: Results of CALGB 9781..” J Clin Oncol 24, no. 18_suppl (June 20, 2006).
       Link to Item
    • Venook, A., D. Niedzwiecki, D. Hollis, S. Sutherland, R. Goldberg, S. Alberts, A. Benson, J. Wade, R. Schilsky, and R. Mayer. “Phase III study of irinotecan/5FU/LV (FOLFIRI) or oxaliplatin/5FU/LV (FOLFOX) ± cetuximab for patients (pts) with untreated metastatic adenocarcinoma of the colon or rectum (MCRC): CALGB 80203 preliminary results..” J Clin Oncol 24, no. 18_suppl (June 20, 2006).
       Link to Item
    • Cancer and Leukemia Group B 89901, Robert J., David P. Ryan, Donna Niedzwiecki, Donna Hollis, Brent E. Mediema, Scott Wadler, Joel E. Tepper, Richard M. Goldberg, and Robert J. Mayer. “Phase I/II study of preoperative oxaliplatin, fluorouracil, and external-beam radiation therapy in patients with locally advanced rectal cancer: Cancer and Leukemia Group B 89901..” J Clin Oncol 24, no. 16 (June 1, 2006): 2557–62. https://doi.org/10.1200/JCO.2006.05.6754.
       Full Text  Link to Item
    • Goldberg, Richard M., Donna Niedzwiecki, Monica Bertagnolli, A William Blackstock, Joel E. Tepper, and Robert J. Mayer. “Cancer and leukemia group B gastrointestinal cancer committee..” Clin Cancer Res 12, no. 11 Pt 2 (June 1, 2006): 3589s-3595s. https://doi.org/10.1158/1078-0432.CCR-06-9004.
       Full Text  Link to Item
    • Vredenburgh, J. J., B. Madan, D. Coniglio, M. Ross, G. Broadwater, D. Niedzwiecki, J. Edwards, et al. “A randomized phase III comparative trial of immediate consolidation with high-dose chemotherapy and autologous peripheral blood progenitor cell support compared to observation with delayed consolidation in women with metastatic breast cancer and only bone metastases following intensive induction chemotherapy..” Bone Marrow Transplant 37, no. 11 (June 2006): 1009–15. https://doi.org/10.1038/sj.bmt.1705367.
       Full Text  Link to Item
    • Thompson, William M., William L. Foster, Erik K. Paulson, Donna Niedzwiecki, Vincent H. S. Low, Lori B. Fulford, Bob W. Broomer, Linda Sanders, and Don C. Rockey. “Causes of errors in polyp detection at air-contrast barium enema examination..” Radiology 239, no. 1 (April 2006): 139–48. https://doi.org/10.1148/radiol.2391050610.
       Full Text  Link to Item
    • Kemeny, Nancy E., Donna Niedzwiecki, Donna R. Hollis, Heinz-Josef Lenz, Robert S. Warren, Michelle J. Naughton, Jane C. Weeks, et al. “Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481)..” J Clin Oncol 24, no. 9 (March 20, 2006): 1395–1403. https://doi.org/10.1200/JCO.2005.03.8166.
       Full Text  Link to Item
    • Redston, Mark, Carolyn C. Compton, Brent W. Miedema, Donna Niedzwiecki, Jeannette M. Dowell, Scott D. Jewell, James M. Fleshman, et al. “Analysis of micrometastatic disease in sentinel lymph nodes from resectable colon cancer: results of Cancer and Leukemia Group B Trial 80001..” J Clin Oncol 24, no. 6 (February 20, 2006): 878–83. https://doi.org/10.1200/JCO.2005.03.6038.
       Full Text  Link to Item
    • Roberts, John D., Donna Niedzwiecki, William E. Carson, Paul B. Chapman, Thomas F. Gajewski, Marc S. Ernstoff, F Stephen Hodi, et al. “Phase 2 study of the g209-2M melanoma peptide vaccine and low-dose interleukin-2 in advanced melanoma: Cancer and Leukemia Group B 509901..” J Immunother 29, no. 1 (January 2006): 95–101. https://doi.org/10.1097/01.cji.0000195295.74104.ad.
       Full Text  Link to Item
    • Venook, Alan P., Charles D. Blanke, Donna Niedzwiecki, Heinz-Josef Lenz, John R. Taylor, Donna R. Hollis, Susan Sutherland, and Richard M. Goldberg. “Cancer and Leukemia Group B/Southwest Oncology Group trial 80405: a phase III trial of chemotherapy and biologics for patients with untreated advanced colorectal adenocarcinoma..” Clin Colorectal Cancer 5, no. 4 (November 2005): 292–94. https://doi.org/10.3816/ccc.2005.n.043.
       Full Text  Link to Item
    • Rizzieri, David A., Martha Wadleigh, Carol J. Wikstrand, Karen P. Mann, Filiz Sen, Bercedis L. Peterson, Donna Niedzwiecki, Alan D. Proia, and Darell D. Bigner. “Tenascin and microvessel stromal changes in patients with non-Hodgkin's lymphoma are isolated to the sites of disease and vary in correlation to disease activity..” Leuk Lymphoma 46, no. 10 (October 2005): 1455–62. https://doi.org/10.1080/10428190500158060.
       Full Text  Link to Item
    • Storms, Robert W., Patrick D. Green, Kristine M. Safford, Donna Niedzwiecki, Christopher R. Cogle, O Michael Colvin, Nelson J. Chao, Henry E. Rice, and Clayton A. Smith. “Distinct hematopoietic progenitor compartments are delineated by the expression of aldehyde dehydrogenase and CD34..” Blood 106, no. 1 (July 1, 2005): 95–102. https://doi.org/10.1182/blood-2004-09-3652.
       Full Text  Link to Item
    • Fuchs, C., J. A. Meyerhardt, D. L. Heseltine, D. Niedzwiecki, D. Hollis, A. T. Chan, L. B. Saltz, R. L. Schilsky, and R. J. Mayer. “Influence of regular aspirin use on survival for patients with stage III colon cancer: Findings from Intergroup trial CALGB 89803..” J Clin Oncol 23, no. 16_suppl (June 2005).
       Link to Item
    • Meyerhardt, J. A., D. Heseltine, D. Niedzwiecki, D. Hollis, L. B. Saltz, R. J. Mayer, R. L. Schilsky, and C. S. Fuchs. “The impact of physical activity on patients with stage III colon cancer: Findings from Intergroup trial CALGB 89803..” J Clin Oncol 23, no. 16_suppl (June 2005).
       Link to Item
    • Wilson, W. H., P. Porcu, D. Hurd, S. E. Martin, M. Czuczman, D. Niedzwiecki, J. D. Saint Louis, et al. “Phase II study of dose-adjusted EPOCH-R in untreated de novo CD20+ diffuse large B-cell lymphoma (DLBCL)-CALGB 50103..” J Clin Oncol 23, no. 16_suppl (June 2005).
       Link to Item
    • Morse, Michael A., Timothy M. Clay, Amy C. Hobeika, Takuya Osada, Shubi Khan, Stephen Chui, Donna Niedzwiecki, Dennis Panicali, Jeffrey Schlom, and H Kim Lyerly. “Phase I study of immunization with dendritic cells modified with fowlpox encoding carcinoembryonic antigen and costimulatory molecules..” Clin Cancer Res 11, no. 8 (April 15, 2005): 3017–24. https://doi.org/10.1158/1078-0432.CCR-04-2172.
       Full Text  Link to Item
    • Su, Zhen, Jens Dannull, Benjamin K. Yang, Philipp Dahm, Doris Coleman, Donna Yancey, Sylvia Sichi, et al. “Telomerase mRNA-transfected dendritic cells stimulate antigen-specific CD8+ and CD4+ T cell responses in patients with metastatic prostate cancer..” J Immunol 174, no. 6 (March 15, 2005): 3798–3807. https://doi.org/10.4049/jimmunol.174.6.3798.
       Full Text  Link to Item
    • Szabolcs, P., K. Park, L. Marti, M. Reese, Y. Lee, D. DeOliveira, L. Sanders, and D. Niedzwiecki. “The impact of immune reconstitution on the development of opportunistic infections (OI) after unrelated umbilical cord blood transplantation (UUCBT). A multivariate analysis of host, graft, and day+50 immune profile.” Bone Marrow Transplantation 35 (March 1, 2005): S93–S93.
       Link to Item
    • Rockey, D. C., E. Paulson, D. Niedzwiecki, W. Davis, H. B. Bosworth, L. Sanders, J. Yee, et al. “Analysis of air contrast barium enema, computed tomographic colonography, and colonoscopy: prospective comparison..” Lancet 365, no. 9456 (January 22, 2005): 305–11. https://doi.org/10.1016/S0140-6736(05)17784-8.
       Full Text  Link to Item
    • Hobeika, Amy C., Michael A. Morse, Takuya Osada, Manar Ghanayem, Donna Niedzwiecki, Robert Barrier, H Kim Lyerly, and Timothy M. Clay. “Enumerating antigen-specific T-cell responses in peripheral blood: a comparison of peptide MHC Tetramer, ELISpot, and intracellular cytokine analysis..” J Immunother 28, no. 1 (January 2005): 63–72. https://doi.org/10.1097/00002371-200501000-00008.
       Full Text  Link to Item
    • Goel, Ajay, Christian N. Arnold, Pierfrancesco Tassone, Dong K. Chang, Donna Niedzwiecki, Jeannette M. Dowell, Linda Wasserman, et al. “Epigenetic inactivation of RUNX3 in microsatellite unstable sporadic colon cancers..” Int J Cancer 112, no. 5 (December 10, 2004): 754–59. https://doi.org/10.1002/ijc.20472.
       Full Text  Link to Item
    • Arnold, Christian N., Ajay Goel, Donna Niedzwiecki, Jeannette M. Dowell, Linda Wasserman, Carolyn Compton, Robert J. Mayer, Monica M. Bertagnolli, and C Richard Boland. “APC promoter hypermethylation contributes to the loss of APC expression in colorectal cancers with allelic loss on 5q..” Cancer Biol Ther 3, no. 10 (October 2004): 960–64. https://doi.org/10.4161/cbt.3.10.1113.
       Full Text  Link to Item
    • Bertagnolli, Monica, Brent Miedema, Mark Redston, Jeannette Dowell, Donna Niedzwiecki, James Fleshman, Jiri Bem, Robert Mayer, Michael Zinner, and Carolyn Compton. “Sentinel node staging of resectable colon cancer: results of a multicenter study..” Ann Surg 240, no. 4 (October 2004): 624–28. https://doi.org/10.1097/01.sla.0000140753.41357.20.
       Full Text  Link to Item
    • Bertagnolli, M. M., M. Redston, B. Miedema, J. Dowell, D. Niedzwiecki, R. Mayer, J. Fleshman, J. Bem, and C. Compton. “Sentinel node staging of resectable colon cancer: Results of CALGB 80001..” J Clin Oncol 22, no. 14_suppl (July 15, 2004).
       Link to Item
    • Colacchio, T. A., D. Niedzwiecki, C. Compton, R. Warren, A. I. Benson, R. Goldberg, D. Kerr, A. Fields, D. Hollis, and R. Mayer. “Phase III trial of adjuvant immunotherapy with MOAb 17-1A following resection for stage II adenocarcinoma of the colon (CALGB 9581)..” J Clin Oncol 22, no. 14_suppl (July 15, 2004).
       Link to Item
    • Kulke, M. H., D. Niedzwiecki, M. A. Tempero, D. R. Hollis, and R. J. Mayer. “A randomized phase II study of gemcitabine/cisplatin, gemcitabine fixed dose rate infusion, gemcitabine/docetaxel, or gemcitabine/irinotecan in patients with metastatic pancreatic cancer (CALGB 89904)..” J Clin Oncol 22, no. 14_suppl (July 15, 2004).
       Link to Item
    • Ryan, D. P., D. Niedzwiecki, D. Hollis, B. E. Miedema, S. Wadler, J. E. Tepper, R. J. Mayer, and R. J. CALGB. “A phase I/II study of preoperative oxaliplatin (O), 5-fluorouracil (5-FU), and external beam radiation therapy (XRT) in locally advanced rectal cancer: CALGB 89901..” J Clin Oncol 22, no. 14_suppl (July 15, 2004).
       Link to Item
    • Saltz, L. B., D. Niedzwiecki, D. Hollis, R. M. Goldberg, A. Hantel, J. P. Thomas, A. L. Fields, G. Carver, and R. J. Mayer. “Irinotecan plus fluorouracil/leucovorin (IFL) versus fluorouracil/leucovorin alone (FL) in stage III colon cancer (intergroup trial CALGB C89803)..” J Clin Oncol 22, no. 14_suppl (July 15, 2004).
       Link to Item
    • Rizzieri, David A., Gregory J. Sand, Dean McGaughey, Joseph O. Moore, Carlos DeCastro, Nelson J. Chao, James J. Vredenburgh, et al. “Low-dose weekly paclitaxel for recurrent or refractory aggressive non-Hodgkin lymphoma..” Cancer 100, no. 11 (June 1, 2004): 2408–14. https://doi.org/10.1002/cncr.20245.
       Full Text  Link to Item
    • Goel, Ajay, Christian N. Arnold, Donna Niedzwiecki, John M. Carethers, Jeannette M. Dowell, Linda Wasserman, Carolyn Compton, Robert J. Mayer, Monica M. Bertagnolli, and C Richard Boland. “Frequent inactivation of PTEN by promoter hypermethylation in microsatellite instability-high sporadic colorectal cancers..” Cancer Res 64, no. 9 (May 1, 2004): 3014–21. https://doi.org/10.1158/0008-5472.can-2401-2.
       Full Text  Link to Item
    • Canellos, George P., David Duggan, Jeffrey Johnson, and Donna Niedzwiecki. “How important is bleomycin in the adriamycin + bleomycin + vinblastine + dacarbazine regimen?.” J Clin Oncol 22, no. 8 (April 15, 2004): 1532–33. https://doi.org/10.1200/JCO.2004.99.010.
       Full Text  Link to Item
    • Rizzieri, David A., Jeffrey L. Johnson, Donna Niedzwiecki, Edward J. Lee, James W. Vardiman, Bayard L. Powell, Maurice Barcos, et al. “Intensive chemotherapy with and without cranial radiation for Burkitt leukemia and lymphoma: final results of Cancer and Leukemia Group B Study 9251..” Cancer 100, no. 7 (April 1, 2004): 1438–48. https://doi.org/10.1002/cncr.20143.
       Full Text  Link to Item
    • Meyerhardt, Jeffrey A., Joel E. Tepper, Donna Niedzwiecki, Donna R. Hollis, A David McCollum, Denise Brady, Michael J. O’Connell, et al. “Impact of body mass index on outcomes and treatment-related toxicity in patients with stage II and III rectal cancer: findings from Intergroup Trial 0114..” J Clin Oncol 22, no. 4 (February 15, 2004): 648–57. https://doi.org/10.1200/JCO.2004.07.121.
       Full Text  Link to Item
    • Arnold, Christian N., Ajay Goel, Carolyn Compton, Victoria Marcus, Donna Niedzwiecki, Jeannette M. Dowell, Linda Wasserman, et al. “Evaluation of microsatellite instability, hMLH1 expression and hMLH1 promoter hypermethylation in defining the MSI phenotype of colorectal cancer..” Cancer Biol Ther 3, no. 1 (January 2004): 73–78. https://doi.org/10.4161/cbt.3.1.590.
       Full Text  Link to Item
    • Meyerhardt, Jeffrey A., Joel E. Tepper, Donna Niedzwiecki, Donna R. Hollis, Deborah Schrag, John Z. Ayanian, Michael J. O’Connell, et al. “Impact of hospital procedure volume on surgical operation and long-term outcomes in high-risk curatively resected rectal cancer: findings from the Intergroup 0114 Study..” J Clin Oncol 22, no. 1 (January 1, 2004): 166–74. https://doi.org/10.1200/JCO.2004.04.172.
       Full Text  Link to Item
    • Long, Gwynn D., Mary Laughlin, Bella Madan, Joanne Kurtzberg, Cristina Gasparetto, Ashley Morris, David Rizzieri, et al. “Unrelated umbilical cord blood transplantation in adult patients..” Biol Blood Marrow Transplant 9, no. 12 (December 2003): 772–80. https://doi.org/10.1016/j.bbmt.2003.08.007.
       Full Text  Link to Item
    • Tepper, J. E., M. O’Connell, D. Hollis, D. Niedzwiecki, E. Cooke, R. J. Mayer, and R. J. Intergroup Study 0114. “Analysis of surgical salvage after failure of primary therapy in rectal cancer: results from Intergroup Study 0114..” J Clin Oncol 21, no. 19 (October 1, 2003): 3623–28. https://doi.org/10.1200/JCO.2003.03.018.
       Full Text  Link to Item
    • Su, Zhen, Jens Dannull, Axel Heiser, Donna Yancey, Scott Pruitt, John Madden, Doris Coleman, Donna Niedzwiecki, Eli Gilboa, and Johannes Vieweg. “Immunological and clinical responses in metastatic renal cancer patients vaccinated with tumor RNA-transfected dendritic cells..” Cancer Res 63, no. 9 (May 1, 2003): 2127–33.
       Link to Item
    • Goel, Ajay, Christian N. Arnold, Donna Niedzwiecki, Dong K. Chang, Luigi Ricciardiello, John M. Carethers, Jeannette M. Dowell, et al. “Characterization of sporadic colon cancer by patterns of genomic instability..” Cancer Res 63, no. 7 (April 1, 2003): 1608–14.
       Link to Item
    • Canellos, George P., and Donna Niedzwiecki. “Long-term follow-up of Hodgkin's disease trial..” N Engl J Med 346, no. 18 (May 2, 2002): 1417–18. https://doi.org/10.1056/NEJM200205023461821.
       Full Text  Link to Item
    • Tepper, J. E., M. O’Connell, D. Niedzwiecki, D. R. Hollis, A. B. Benson, B. Cummings, L. L. Gunderson, J. S. Macdonald, J. A. Martenson, and R. J. Mayer. “Adjuvant therapy in rectal cancer: analysis of stage, sex, and local control--final report of intergroup 0114..” J Clin Oncol 20, no. 7 (April 1, 2002): 1744–50. https://doi.org/10.1200/JCO.2002.07.132.
       Full Text  Link to Item
    • Long, G. D., M. Laughlin, B. Madan, J. Kurtzberg, P. Rubinstein, C. Gasparetto, A. Morris, et al. “Transplantation of unrelated umbilical cord blood in adult patients..” Leukemia 16, no. 3 (March 1, 2002): 411–411.
       Link to Item
    • Heiser, Axel, Doris Coleman, Jens Dannull, Donna Yancey, Margaret A. Maurice, Costas D. Lallas, Philipp Dahm, Donna Niedzwiecki, Eli Gilboa, and Johannes Vieweg. “Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors..” J Clin Invest 109, no. 3 (February 2002): 409–17. https://doi.org/10.1172/JCI14364.
       Full Text  Link to Item
    • Rizzieri, D. A., C. DeCastro, J. P. Gockerman, D. Niedzwiecki, J. J. Vredenburgh, C. Gasparetto, G. Long, et al. “Low dose, weekly, paclitaxel as salvage therapy for non-Hodgkins lymphoma (NHL)..” Blood 98, no. 11 (November 16, 2001): 246B-246B.
       Link to Item
    • Rizzieri, D. A., G. Akabani, R. E. Coleman, M. R. Zalutsky, D. Niedzwiecki, N. Payne, C. Wikstrand, and D. D. Bigner. “Radiolabeled anti-tenascin antibody for refractory non-Hodgkins lymphoma (NHL)..” Blood 98, no. 11 (November 16, 2001): 247B-247B.
       Link to Item
    • Rizzieri, D. A., G. D. Long, J. J. Vredenburgh, C. Gasparetto, A. Morris, D. Niedzwiecki, M. Lassiter, et al. “Durable engraftment of mismatched unrelated cord blood following a non-myeloablative preparative regimen for adults..” Blood 98, no. 11 (November 16, 2001): 185A-185A.
       Link to Item
    • Rizzieri, D. A., G. D. Long, J. J. Vredenburgh, C. Gasparetto, A. Morris, M. Lassiter, J. Loftis, et al. “Non-myeloablative allogeneic transplantation using T depleted matched sibling peripheral blood stem cells..” Blood 98, no. 11 (November 16, 2001): 420A-421A.
       Link to Item
    • Rizzieri, D. A., G. D. Long, J. J. Vredenburgh, C. Gasparetto, A. Morris, M. Lassiter, J. Loftis, et al. “Non-myeloablative transplantation using CAMPATH 1H for T depletion of mismatched, related donor peripheral blood stem cells..” Blood 98, no. 11 (November 16, 2001): 669A-669A.
       Link to Item
    • Rizzieri, D. A., J. P. Gockerman, J. O. Moore, C. DeCastro, G. D. Long, J. J. Vredenburgh, D. Niedzwiecki, et al. “Dose dense, high intensity therapy for mantle cell lymphoma..” Blood 98, no. 11 (November 16, 2001): 681A-682A.
       Link to Item
    • Szabolcs, P., K. D. Park, M. Reese, L. Marti, G. Broadwater, D. Niedzwiecki, D. DeOliveira, and J. Kurtzberg. “Reconstitution of T cell and dendritic cell immunity 50 days post unrelated cord blood transplant predicts the incidence of opportunistic infections and acute GVHD in children..” Blood 98, no. 11 (November 16, 2001): 204A-204A.
       Link to Item
    • Wadleigh, M., D. Niedzwiecki, P. Davis, N. Payne, F. Sen, K. P. Mann, A. Proia, D. Hollis, and D. A. Rizzieri. “Increased microvessel density in non-Hodgkin's lymphoma (NHL) is localized to the site of disease changes in accordance with disease response..” Blood 98, no. 11 (November 16, 2001): 236B-236B.
       Link to Item
    • Lichtman, S. M., G. Petroni, R. L. Schilsky, J. L. Johnson, R. T. Perri, D. Niedzwiecki, J. Sklar, M. Barcos, and B. A. Peterson. “High dose cyclophosphamide plus recombinant human granulocyte-colony stimulating factor (rhG-CSF) in the treatment of follicular, low grade non-Hodgkin's lymphoma: CALGB 9150..” Leuk Lymphoma 42, no. 6 (November 2001): 1255–64. https://doi.org/10.3109/10428190109097750.
       Full Text  Link to Item
    • Bortell, R., J. Moss, R. C. McKenna, M. R. Rigby, D. Niedzwiecki, L. A. Stevens, W. A. Patton, J. P. Mordes, D. L. Greiner, and A. A. Rossini. “Nicotinamide adenine dinucleotide (NAD) and its metabolites inhibit T lymphocyte proliferation: role of cell surface NAD glycohydrolase and pyrophosphatase activities..” J Immunol 167, no. 4 (August 15, 2001): 2049–59. https://doi.org/10.4049/jimmunol.167.4.2049.
       Full Text  Link to Item
    • Sargent, D. J., D. Niedzwiecki, M. J. O’Connell, and R. L. Schilsky. “Recommendation for caution with irinotecan, fluorouracil, and leucovorin for colorectal cancer..” N Engl J Med 345, no. 2 (July 12, 2001): 144–45. https://doi.org/10.1056/NEJM200107123450213.
       Full Text  Link to Item
    • Arnold, C. N., A. Goel, D. K. Chang, L. Wasserman, C. Compton, D. Niedzwiecki, R. J. Mayer, M. M. Bertagnolli, and C. R. Boland. “Microsatellite high (MSI-H) tumors are not associated with LOH at the APC locus compared to microsatellite-low/stable (MSI-L/MSS) tumors.” Gastroenterology 120, no. 5 (April 1, 2001): A296–A296.
       Link to Item
    • Arnold, C. N., A. Goel, J. M. Carethers, L. Wasserman, C. Compton, D. Niedzwiecki, R. J. Mayer, M. M. Bertagnolli, and C. R. Boland. “A panel of mono- and dinucleotide microsatellite markers is required for reliable determination of the MSI status in colorectal cancer.” Gastroenterology 120, no. 5 (April 1, 2001): A599–A599.
       Link to Item
    • Goel, A., C. N. Arnold, D. K. Chang, L. Ricciardiello, D. P. Chauhan, J. M. Carethers, L. Wasserman, et al. “Chromosomal vs microsatellite instability in colorectal cancers: Evidence for previously unrecognized pathways.” Gastroenterology 120, no. 5 (April 1, 2001): A163–A163.
       Link to Item
    • Goel, A., C. N. Arnold, L. Ricciardiello, D. K. Chang, L. Wasserman, C. Compton, D. Niedzwiecki, R. J. Mayer, M. M. Bertagnolli, and R. Boland. “Somatic frameshift mutations in MBD4 (MED1) are not exclusively associated with microsatellite high (MSI-H) colorectal tumors.” Gastroenterology 120, no. 5 (April 1, 2001): A293–A293.
       Link to Item
    • Meropol, N. J., D. Niedzwiecki, D. Hollis, R. L. Schilsky, R. J. Mayer, and R. J. Cancer and Leukemia Group B. “Phase II study of oral eniluracil, 5-fluorouracil, and leucovorin in patients with advanced colorectal carcinoma..” Cancer 91, no. 7 (April 1, 2001): 1256–63. https://doi.org/10.1002/1097-0142(20010401)91:7<1256::aid-cncr1126>3.0.co;2-v.
       Full Text  Link to Item
    • Tepper, J. E., M. J. O’Connell, D. Niedzwiecki, D. Hollis, C. Compton, A. B. Benson, B. Cummings, L. Gunderson, J. S. Macdonald, and R. J. Mayer. “Impact of number of nodes retrieved on outcome in patients with rectal cancer..” J Clin Oncol 19, no. 1 (January 1, 2001): 157–63. https://doi.org/10.1200/JCO.2001.19.1.157.
       Full Text  Link to Item
    • Morse, M. A., S. Nair, M. Fernandez-Casal, Y. Deng, M. St Peter, R. Williams, A. Hobeika, et al. “Preoperative mobilization of circulating dendritic cells by Flt3 ligand administration to patients with metastatic colon cancer..” J Clin Oncol 18, no. 23 (December 1, 2000): 3883–93. https://doi.org/10.1200/JCO.2000.18.23.3883.
       Full Text  Link to Item
    • Szabolcs, P., K. D. Park, M. Reese, D. Niedzwiecki, N. J. Chao, and J. Kurtzberg. “Predictive value of day+50 immune reconstitution on the incidence of opportunistic infections and acute GVHD following unrelated cord blood transplants in children..” Blood 96, no. 11 (November 16, 2000): 789A-789A.
       Link to Item
    • Lichtman, S. M., D. Niedzwiecki, M. Barcos, T. L. Carlisle, M. R. Cooper, J. L. Johnson, and B. A. Peterson. “Phase II study of infusional chemotherapy with doxorubicin, vincristine and etoposide plus cyclophosphamide and prednisone (I-CHOPE) in resistant diffuse aggressive non-Hodgkin's lymphoma: CALGB 9255. Cancer and Leukemia Group B..” Ann Oncol 11, no. 9 (September 2000): 1141–46. https://doi.org/10.1023/a:1008395400069.
       Full Text  Link to Item
    • Rizzieri, D. A., C. J. Wikstrand, K. P. Mann, F. Sen, A. D. Proia, D. Niedzwiecki, D. D. Bigner, and J. Vredenburgh. “Markers of angiogenesis, factor VIII and tenascin, correlate with disease activity in patients with Non-Hodgkin's Lymphoma..” Blood 94, no. 10 (November 15, 1999): 253B-253B.
       Link to Item
    • Stason, W. B., C. H. Schmid, D. Niedzwiecki, G. W. Whiting, J. F. Caubet, D. Cory, D. Luo, S. D. Ross, and T. C. Chalmers. “Safety of nifedipine in angina pectoris: a meta-analysis..” Hypertension 33, no. 1 (January 1999): 24–31. https://doi.org/10.1161/01.hyp.33.1.24.
       Full Text  Link to Item
    • Stason, W. B., C. H. Schmid, D. Niedzwiecki, G. W. Whiting, J. F. Caubet, D. Luo, S. D. Ross, and T. C. Chalmers. “Erratum: Safety of nifedipine in patients with hypertension: A meta- analysis (Hypertension 30 (7-14)).” Hypertension 34, no. 3 (January 1, 1999).
    • Jiang, J., J. McMurtry, D. Niedzwiecki, and S. A. Goldman. “Insulin-like growth factor-1 is a radial cell-associated neurotrophin that promotes neuronal recruitment from the adult songbird edpendyma/subependyma..” J Neurobiol 36, no. 1 (July 1998): 1–15. https://doi.org/10.1002/(sici)1097-4695(199807)36:1<1::aid-neu1>3.0.co;2-6.
       Full Text  Link to Item
    • Stason, W. B., C. H. Schmid, D. Niedzwiecki, G. W. Whiting, J. F. Caubet, D. Luo, S. D. Ross, and T. C. Chalmers. “Safety of nifedipine in patients with hypertension: a meta-analysis..” Hypertension 30, no. 1 Pt 1 (July 1997): 7–14. https://doi.org/10.1161/01.hyp.30.1.7.
       Full Text  Link to Item
    • Goldman, S. A., A. Zukhar, K. Barami, T. Mikawa, and D. Niedzwiecki. “Ependymal/subependymal zone cells of postnatal and adult songbird brain generate both neurons and nonneuronal siblings in vitro and in vivo.” Journal of Neurobiology 30, no. 4 (August 1, 1996): 505–20. https://doi.org/10.1002/(SICI)1097-4695(199608)30:4<505::AID-NEU6>3.0.CO;2-7.
       Full Text
    • Goldman, S. A., A. Zukhar, K. Barami, T. Mikawa, and D. Niedzwiecki. “Ependymal/subependymal zone cells of postnatal and adult songbird brain generate both neurons and nonneuronal siblings in vitro and in vivo..” J Neurobiol 30, no. 4 (August 1996): 505–20. https://doi.org/10.1002/(SICI)1097-4695(199608)30:4<505::AID-NEU6>3.0.CO;2-7.
       Full Text  Link to Item
    • Kelsen, D. P., R. K. Portenoy, H. T. Thaler, D. Niedzwiecki, S. D. Passik, Y. Tao, W. Banks, M. F. Brennan, and K. M. Foley. “Pain and depression in patients with newly diagnosed pancreas cancer..” J Clin Oncol 13, no. 3 (March 1995): 748–55. https://doi.org/10.1200/JCO.1995.13.3.748.
       Full Text  Link to Item
    • Albino, A. P., J. Jaehne, N. Altorki, M. Blundell, C. Urmacher, G. Lauwers, D. Niedzwiecki, and D. P. Kelsen. “Amplification of HER-2/neu gene in human gastric adenocarcinomas: correlation with primary site..” Eur J Surg Oncol 21, no. 1 (February 1995): 56–60. https://doi.org/10.1016/s0748-7983(05)80069-1.
       Full Text  Link to Item
    • Doukas, J., J. P. Mordes, C. Swymer, D. Niedzwiecki, R. Mason, J. Rozing, A. A. Rossini, and D. L. Greiner. “Thymic epithelial defects and predisposition to autoimmune disease in BB rats..” Am J Pathol 145, no. 6 (December 1994): 1517–25.
       Link to Item
    • Rivoire, M. L., K. Yoshida, E. J. Voiglio, C. R. Divgi, D. Niedzwiecki, D. Chapman, A. M. Cohen, and E. R. Sigurdson. “Intraportal injection of monoclonal antibody in nude mice bearing hepatic metastases..” J Surg Oncol 54, no. 2 (October 1993): 71–77. https://doi.org/10.1002/jso.2930540203.
       Full Text  Link to Item
    • Saltz, L., M. Sirott, C. Young, W. Tong, D. Niedzwiecki, Y. Tzy-Jyun, Y. Tao, B. Trochanowski, P. Wright, and K. Barbosa. “Phase I clinical and pharmacology study of topotecan given daily for 5 consecutive days to patients with advanced solid tumors, with attempt at dose intensification using recombinant granulocyte colony-stimulating factor..” J Natl Cancer Inst 85, no. 18 (September 15, 1993): 1499–1507. https://doi.org/10.1093/jnci/85.18.1499.
       Full Text  Link to Item
    • Göker, E., J. T. Lin, T. Trippett, Y. Elisseyeff, W. P. Tong, D. Niedzwiecki, C. Tan, P. Steinherz, B. I. Schweitzer, and J. R. Bertino. “Decreased polyglutamylation of methotrexate in acute lymphoblastic leukemia blasts in adults compared to children with this disease..” Leukemia 7, no. 7 (July 1993): 1000–1004.
       Link to Item
    • Saltz, L., B. Trochanowski, M. Buckley, B. Heffernan, D. Niedzwiecki, Y. Tao, and D. Kelsen. “Octreotide as an antineoplastic agent in the treatment of functional and nonfunctional neuroendocrine tumors..” Cancer 72, no. 1 (July 1, 1993): 244–48. https://doi.org/10.1002/1097-0142(19930701)72:1<244::aid-cncr2820720143>3.0.co;2-q.
       Full Text  Link to Item
    • Kemeny, N., J. A. Conti, E. Sigurdson, A. Cohen, K. Seiter, R. Lincer, D. Niedzwiecki, J. Botet, D. Chapman, and P. Costa. “A pilot study of hepatic artery floxuridine combined with systemic 5-fluorouracil and leucovorin. A potential adjuvant program after resection of colorectal hepatic metastases..” Cancer 71, no. 6 (March 15, 1993): 1964–71. https://doi.org/10.1002/1097-0142(19930315)71:6<1964::aid-cncr2820710607>3.0.co;2-t.
       Full Text  Link to Item
    • Atiq, O. T., D. P. Kelsen, M. H. Shiu, L. Saltz, W. Tong, D. Niedzwiecki, B. Trochanowski, S. Lin, F. Toomasi, and M. Brennan. “Phase II trial of postoperative adjuvant intraperitoneal cisplatin and fluorouracil and systemic fluorouracil chemotherapy in patients with resected gastric cancer..” J Clin Oncol 11, no. 3 (March 1993): 425–33. https://doi.org/10.1200/JCO.1993.11.3.425.
       Full Text  Link to Item
    • Kemeny, N., A. Cohen, K. Seiter, J. A. Conti, E. R. Sigurdson, Y. Tao, D. Niedzwiecki, J. Botet, and A. Budd. “Randomized trial of hepatic arterial floxuridine, mitomycin, and carmustine versus floxuridine alone in previously treated patients with liver metastases from colorectal cancer..” J Clin Oncol 11, no. 2 (February 1993): 330–35. https://doi.org/10.1200/JCO.1993.11.2.330.
       Full Text  Link to Item
    • Niedt, G. W., P. L. Myskowski, C. Urmacher, D. Niedzwiecki, D. Chapman, S. E. Krown, and B. Safai. “Histologic predictors of survival in acquired immunodeficiency syndrome-associated Kaposi's sarcoma..” Hum Pathol 23, no. 12 (December 1992): 1419–26. https://doi.org/10.1016/0046-8177(92)90063-9.
       Full Text  Link to Item
    • Li, W. W., J. T. Lin, B. I. Schweitzer, W. P. Tong, D. Niedzwiecki, and J. R. Bertino. “Intrinsic resistance to methotrexate in human soft tissue sarcoma cell lines..” Cancer Res 52, no. 14 (July 15, 1992): 3908–13.
       Link to Item
    • Goldman, S. A., A. Zaremba, and D. Niedzwiecki. “In vitro neurogenesis by neuronal precursor cells derived from the adult songbird brain..” J Neurosci 12, no. 7 (July 1992): 2532–41.
       Link to Item
    • Rusch, V. W., D. Niedzwiecki, Y. Tao, C. Menendez-Botet, A. Dnistrian, D. Kelsen, L. Saltz, and M. Markman. “Intrapleural cisplatin and mitomycin for malignant mesothelioma following pleurectomy: pharmacokinetic studies..” J Clin Oncol 10, no. 6 (June 1992): 1001–6. https://doi.org/10.1200/JCO.1992.10.6.1001.
       Full Text  Link to Item
    • Kemeny, N., J. A. Conti, K. Seiter, D. Niedzwiecki, J. Botet, D. Martin, P. Costa, J. Wiseberg, and W. McCulloch. “Biochemical modulation of bolus fluorouracil by PALA in patients with advanced colorectal cancer..” J Clin Oncol 10, no. 5 (May 1992): 747–52. https://doi.org/10.1200/JCO.1992.10.5.747.
       Full Text  Link to Item
    • Kelsen, D., O. T. Atiq, L. Saltz, D. Niedzwiecki, D. Ginn, D. Chapman, R. Heelan, C. Lightdale, V. Vinciguerra, and M. Brennan. “FAMTX versus etoposide, doxorubicin, and cisplatin: a random assignment trial in gastric cancer..” J Clin Oncol 10, no. 4 (April 1992): 541–48. https://doi.org/10.1200/JCO.1992.10.4.541.
       Full Text  Link to Item
    • Kostakoglu, L., S. D. Yeh, C. Portlock, R. Heelan, T. J. Yao, D. Niedzwiecki, and S. M. Larson. “Validation of gallium-67-citrate single-photon emission computed tomography in biopsy-confirmed residual Hodgkin's disease in the mediastinum..” J Nucl Med 33, no. 3 (March 1992): 345–50.
       Link to Item
    • Atiq, O. T., N. Kemeny, D. Niedzwiecki, and J. Botet. “Treatment of unresectable primary liver cancer with intrahepatic fluorodeoxyuridine and mitomycin C through an implantable pump..” Cancer 69, no. 4 (February 15, 1992): 920–24. https://doi.org/10.1002/1097-0142(19920215)69:4<920::aid-cncr2820690414>3.0.co;2-y.
       Full Text  Link to Item
    • Sutanto-Ward, E., E. R. Sigurdson, S. Tremiterra, R. Lincer, D. Chapman, and D. Niedzwiecki. “Adjuvant chemotherapy for colorectal hepatic metastases: role of route of administration and timing..” Surg Oncol 1, no. 1 (February 1992): 87–95. https://doi.org/10.1016/0960-7404(92)90061-o.
       Full Text  Link to Item
    • Kemeny, N., K. Seiter, D. Niedzwiecki, D. Chapman, E. Sigurdson, A. Cohen, J. Botet, P. Oderman, and P. Murray. “A randomized trial of intrahepatic infusion of fluorodeoxyuridine with dexamethasone versus fluorodeoxyuridine alone in the treatment of metastatic colorectal cancer..” Cancer 69, no. 2 (January 15, 1992): 327–34. https://doi.org/10.1002/1097-0142(19920115)69:2<327::aid-cncr2820690209>3.0.co;2-u.
       Full Text  Link to Item
    • Kemeny, N., K. Seiter, D. Martin, C. Urmacher, D. Niedzwiecki, R. C. Kurtz, P. Costa, and M. Murray. “A new syndrome: ascites, hyperbilirubinemia, and hypoalbuminemia after biochemical modulation of fluorouracil with N-phosphonacetyl-L-aspartate (PALA).” Ann Intern Med 115, no. 12 (December 15, 1991): 946–51. https://doi.org/10.7326/0003-4819-115-12-946.
       Full Text  Link to Item
    • Kelsen, D., C. Hudis, D. Niedzwiecki, J. Dougherty, E. Casper, J. Botet, V. Vinciguerra, and R. Rosenbluth. “A phase III comparison trial of streptozotocin, mitomycin, and 5-fluorouracil with cisplatin, cytosine arabinoside, and caffeine in patients with advanced pancreatic carcinoma..” Cancer 68, no. 5 (September 1, 1991): 965–69. https://doi.org/10.1002/1097-0142(19910901)68:5<965::aid-cncr2820680509>3.0.co;2-2.
       Full Text  Link to Item
    • Romanini, A., J. T. Lin, D. Niedzwiecki, M. Bunni, D. G. Priest, and J. R. Bertino. “Role of folylpolyglutamates in biochemical modulation of fluoropyrimidines by leucovorin..” Cancer Res 51, no. 3 (February 1, 1991): 789–93.
       Link to Item
    • Krown, S. E., D. Niedzwiecki, R. B. Bhalla, N. Flomenberg, D. Bundow, and D. Chapman. “Relationship and prognostic value of endogenous interferon-alpha, beta 2-microglobulin, and neopterin serum levels in patients with Kaposi sarcoma and AIDS..” J Acquir Immune Defic Syndr 4, no. 9 (1991): 871–80.
       Link to Item
    • Lin, J. T., W. P. Tong, T. M. Trippett, D. Niedzwiecki, Y. Tao, C. Tan, P. Steinherz, B. I. Schweitzer, and J. R. Bertino. “Basis for natural resistance to methotrexate in human acute non-lymphocytic leukemia..” Leuk Res 15, no. 12 (1991): 1191–96. https://doi.org/10.1016/0145-2126(91)90189-z.
       Full Text  Link to Item
    • Kelsen, D. P., B. Minsky, M. Smith, J. Beitler, D. Niedzwiecki, D. Chapman, M. Bains, M. Burt, R. Heelan, and B. Hilaris. “Preoperative therapy for esophageal cancer: a randomized comparison of chemotherapy versus radiation therapy..” J Clin Oncol 8, no. 8 (August 1990): 1352–61. https://doi.org/10.1200/JCO.1990.8.8.1352.
       Full Text  Link to Item
    • Niedzwiecki, D., and J. S. Simonoff. “Estimation and inference in pharmacokinetic models: the effectiveness of model reformulation and resampling methods for functions of parameters..” J Pharmacokinet Biopharm 18, no. 4 (August 1990): 361–77. https://doi.org/10.1007/bf01062274.
       Full Text  Link to Item
    • Grant, I. H., J. W. Gold, M. Rosenblum, D. Niedzwiecki, and D. Armstrong. “Toxoplasma gondii serology in HIV-infected patients: the development of central nervous system toxoplasmosis in AIDS..” Aids 4, no. 6 (June 1990): 519–21.
       Link to Item
    • Krown, S. E., J. W. Gold, D. Niedzwiecki, D. Bundow, N. Flomenberg, B. Gansbacher, and B. J. Brew. “Interferon-alpha with zidovudine: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the acquired immunodeficiency syndrome (AIDS).” Ann Intern Med 112, no. 11 (June 1, 1990): 812–21. https://doi.org/10.7326/0003-4819-112-11-812.
       Full Text  Link to Item
    • Bovbjerg, D. H., W. H. Redd, L. A. Maier, J. C. Holland, L. M. Lesko, D. Niedzwiecki, S. C. Rubin, and T. B. Hakes. “Anticipatory immune suppression and nausea in women receiving cyclic chemotherapy for ovarian cancer..” J Consult Clin Psychol 58, no. 2 (April 1990): 153–57. https://doi.org/10.1037//0022-006x.58.2.153.
       Full Text  Link to Item
    • Kambhu, S. A., D. P. Kelsen, J. Fiore, D. Niedzwiecki, D. Chapman, V. Vinciguerra, and R. Rosenbluth. “Metastatic adenocarcinomas of unknown primary site. Prognostic variables and treatment results..” Am J Clin Oncol 13, no. 1 (February 1990): 55–60. https://doi.org/10.1097/00000421-199002000-00015.
       Full Text  Link to Item
    • Kemeny, N., K. Israel, D. Niedzwiecki, D. Chapman, J. Botet, B. Minsky, V. Vinciguerra, R. Rosenbluth, B. Bosselli, and C. Cochran. “Randomized study of continuous infusion fluorouracil versus fluorouracil plus cisplatin in patients with metastatic colorectal cancer..” J Clin Oncol 8, no. 2 (February 1990): 313–18. https://doi.org/10.1200/JCO.1990.8.2.313.
       Full Text  Link to Item
    • Motzer, R. J., D. Niedzwiecki, M. Isaacs, C. Menendez-Botet, W. P. Tong, C. Flombaum, H. I. Scher, and G. J. Bosl. “Carboplatin-based chemotherapy with pharmacokinetic analysis for patients with hemodialysis-dependent renal insufficiency..” Cancer Chemother Pharmacol 27, no. 3 (1990): 234–38. https://doi.org/10.1007/bf00685719.
       Full Text  Link to Item
    • Niedt, G. W., P. L. Myskowski, C. Urmacher, D. Niedzwiecki, D. Chapman, and B. Safai. “Histology of early lesions of AIDS-associated Kaposi's sarcoma..” Mod Pathol 3, no. 1 (January 1990): 64–70.
       Link to Item
    • Rivoire, M., K. Yoshida, C. Divgi, D. Niedzwiecki, D. Chapman, and E. Sigurdson. “[Intraportal injection of specific monoclonal antibody in nude mice with liver metastasis]..” Chirurgie 116, no. 8–9 (1990): 721–29.
       Link to Item
    • Schneider, A., N. Kemeny, D. Chapman, D. Niedzwiecki, and P. Oderman. “Intrahepatic mitomycin C as a salvage treatment for patients with hepatic metastases from colorectal carcinoma..” Cancer 64, no. 11 (December 1, 1989): 2203–6. https://doi.org/10.1002/1097-0142(19891201)64:11<2203::aid-cncr2820641103>3.0.co;2-o.
       Full Text  Link to Item
    • Dougherty, J. B., D. Kelsen, N. Kemeny, G. Magill, J. Botet, and D. Niedzwiecki. “Advanced pancreatic cancer: a phase I-II trial of cisplatin, high-dose cytarabine, and caffeine..” J Natl Cancer Inst 81, no. 22 (November 15, 1989): 1735–38. https://doi.org/10.1093/jnci/81.22.1735.
       Full Text  Link to Item
    • Nanus, D. M., D. P. Kelsen, D. Niedzwiecki, D. Chapman, M. Brennan, E. Cheng, and M. Melamed. “Flow cytometry as a predictive indicator in patients with operable gastric cancer..” J Clin Oncol 7, no. 8 (August 1989): 1105–12. https://doi.org/10.1200/JCO.1989.7.8.1105.
       Full Text  Link to Item
    • Niedzwiecki, D. M., L. X. Cubeddu, and R. B. Mailman. “Comparative antidopaminergic properties of thioridazine, mesoridazine and sulforidazine on the corpus striatum..” J Pharmacol Exp Ther 250, no. 1 (July 1989): 117–25.
       Link to Item
    • Kemeny, N., D. Niedzwiecki, B. Reichman, J. Botet, V. Vinciguerra, R. Michaelson, R. Rosenbluth, and S. Deonarine. “Cisplatin and 5-fluorouracil infusion for metastatic colorectal carcinoma. Differences in survival in two patient groups with similar response rates..” Cancer 63, no. 6 (March 15, 1989): 1065–69. https://doi.org/10.1002/1097-0142(19890315)63:6<1065::aid-cncr2820630604>3.0.co;2-4.
       Full Text  Link to Item
    • Kemeny, N., D. Niedzwiecki, B. Shurgot, and P. Oderman. “Prognostic variables in patients with hepatic metastases from colorectal cancer. Importance of medical assessment of liver involvement..” Cancer 63, no. 4 (February 15, 1989): 742–47. https://doi.org/10.1002/1097-0142(19890215)63:4<742::aid-cncr2820630423>3.0.co;2-t.
       Full Text  Link to Item
    • Frame, J., D. Kelsen, N. Kemeny, E. Cheng, D. Niedzwiecki, R. Heelan, and R. Lippermann. “A phase II trial of streptozotocin and adriamycin in advanced APUD tumors..” Am J Clin Oncol 11, no. 4 (August 1988): 490–95. https://doi.org/10.1097/00000421-198808000-00015.
       Full Text  Link to Item
    • Myskowski, P. L., D. Niedzwiecki, B. A. Shurgot, D. Kaufman, S. E. Krown, L. Nisce, and B. Safai. “AIDS-associated Kaposi's sarcoma: variables associated with survival..” J Am Acad Dermatol 18, no. 6 (June 1988): 1299–1306. https://doi.org/10.1016/s0190-9622(88)70138-3.
       Full Text  Link to Item
    • Scher, H. I., B. Shank, R. Chapman, N. Geller, C. Pinsky, R. Gralla, D. Kelsen, G. Bosl, R. Golbey, and G. Petroni. “Randomized trial of combined modality therapy with and without thymosin fraction V in the treatment of small cell lung cancer..” Cancer Res 48, no. 6 (March 15, 1988): 1663–70.
       Link to Item
    • Glazer, W. M., H. Morgenstern, D. Niedzwiecki, and J. Hughes. “Heterogeneity of tardive dyskinesia. A multivariate analysis..” Br J Psychiatry 152 (February 1988): 253–59. https://doi.org/10.1192/bjp.152.2.253.
       Full Text  Link to Item
    • Glazer, W. M., H. Morgenstern, D. Niedzwiecki, and J. Hughes. “Heterogeneity of tardive dyskinesia. A multivariate analysis.” British Journal of Psychiatry 152, no. FEB. (January 1, 1988): 253–59.
    • Allen-Mersh, T. G., N. Kemeny, D. Niedzwiecki, B. Shurgot, and J. M. Daly. “Significance of a fall in serum CEA concentration in patients treated with cytotoxic chemotherapy for disseminated colorectal cancer..” Gut 28, no. 12 (December 1987): 1625–29. https://doi.org/10.1136/gut.28.12.1625.
       Full Text  Link to Item
    • Fanucchi, M. P., T. D. Walsh, M. Fleisher, G. Lokos, L. Williams, C. Cassidy, P. Vidal, T. C. Chou, D. Niedzwiecki, and C. W. Young. “Phase I and clinical pharmacology study of trimetrexate administered weekly for three weeks..” Cancer Res 47, no. 12 (June 15, 1987): 3303–8.
       Link to Item
    • Morgenstern, H., W. M. Glazer, D. Niedzwiecki, and P. Nourjah. “The impact of neuroleptic medication on tardive dyskinesia: a meta-analysis of published studies..” Am J Public Health 77, no. 6 (June 1987): 717–24. https://doi.org/10.2105/ajph.77.6.717.
       Full Text  Link to Item
    • Sternberg, C. N., P. P. Sordillo, E. Cheng, Y. J. Chuang, and D. Niedzwiecki. “Evaluation of new anticancer agents against human pancreatic carcinomas in nude mice..” Am J Clin Oncol 10, no. 3 (June 1987): 219–21. https://doi.org/10.1097/00000421-198706000-00009.
       Full Text  Link to Item
    • Fanucchi, M. P., J. J. Kinahan, L. L. Samuels, C. Hancock, T. C. Chou, D. Niedzwiecki, F. Farag, P. M. Vidal, J. I. DeGraw, and S. S. Sternberg. “Toxicity, elimination, and metabolism of 10-ethyl-10-deazaaminopterin in rats and dogs..” Cancer Res 47, no. 9 (May 1, 1987): 2334–39.
       Link to Item
    • Krown, S. E., D. Mintzer, S. Cunningham-Rundles, D. Niedzwiecki, M. Krim, A. I. Einzig, J. L. Gabrilove, B. Shurgot, and J. Gessula. “High-dose human lymphoblastoid interferon in metastatic colorectal cancer: clinical results and modification of biological responses..” Cancer Treat Rep 71, no. 1 (January 1987): 39–45.
       Link to Item
    • Bajorin, D. F., G. J. Bosl, N. W. Alcock, D. Niedzwiecki, E. Gallina, and B. Shurgot. “Pharmacokinetics of cis-diamminedichloroplatinum(II) after administration in hypertonic saline..” Cancer Res 46, no. 11 (November 1986): 5969–72.
       Link to Item
    • Scher, H. I., C. Sternberg, W. D. Heston, R. C. Watson, D. Niedzwiecki, T. Smart, P. Hollander, and A. Yagoda. “Etoposide in prostatic cancer: experimental studies and phase II trial in patients with bidimensionally measurable disease..” Cancer Chemother Pharmacol 18, no. 1 (1986): 24–26. https://doi.org/10.1007/bf00253058.
       Full Text  Link to Item
    • Hancock, C., D. Bacha, and D. Niedzwiecki. “Pharmacokinetics of intravenous (IV) and oral (PO) idarubicin (4DMDR) in children with cancer.” Proceedings of the American Association for Cancer Research VOL. 26 (January 1, 1985).
    • Hancock, C., D. Niedzwiecki, and D. Merke. “Pharmacokinetics of idarubicin (4-DMDR) with or without cytarabine (ARA-C) in patients (pts) with relapsed leukemia.” Proceedings of the American Association for Cancer Research VOL. 26 (January 1, 1985).

  • Conference Papers

    • Posner, Shai, Raymond T. Finn, Rahul A. Shimpi, Richard K. Wood, Deborah Fisher, Matthew G. Hartwig, Jacob Klapper, et al. “Esophageal contractility increases and gastroesophageal reflux does not worsen after lung transplantation..” In Dis Esophagus, 32:1–8, 2019. https://doi.org/10.1093/dote/doz039.
       Full Text  Link to Item
    • Mettu, Niharika B., Donna Niedzwiecki, Christel Rushing, Andrew B. Nixon, Jingquan Jia, Sherri Haley, Wanda Honeycutt, Herbert Hurwitz, Johanna C. Bendell, and Hope Uronis. “A phase I study of gemcitabine + dasatinib (gd) or gemcitabine + dasatinib + cetuximab (GDC) in refractory solid tumors..” In Cancer Chemother Pharmacol, 83:1025–35, 2019. https://doi.org/10.1007/s00280-019-03805-6.
       Full Text  Link to Item
    • Yang, Nancy, Shai Posner, Raymond T. Finn, Alice Parish, Rahul A. Shimpi, Richard K. Wood, Deborah A. Fisher, et al. “IDENTIFYING GASTROESOPHAGEAL REFLUX DISEASE POST-LUNG TRANSPLANT IS NOT IMPROVED WITH INTRALUMINAL IMPEDANCE VERSUS PH-METRY.” In Gastroenterology, 156:S297–98. W B SAUNDERS CO-ELSEVIER INC, 2019.
       Link to Item
    • Koontz, B., E. Chittester, D. Niedzwiecki, A. Hunt, and A. Ahmad. “154 Is Statin Use at Time of Prostate Cancer Radiation Associated with Protection of Patient-reported Erectile Function?.” In The Journal of Sexual Medicine, 16:S78–79. Elsevier BV, 2019. https://doi.org/10.1016/j.jsxm.2019.01.162.
       Full Text
    • Hong, J. C., D. Niedzwiecki, M. Palta, and J. D. Tenenbaum. “Predicting Emergency Visits and Hospital Admissions in Radiation and Chemoradiation: Performance of a Pre-Treatment Machine Learning Algorithm on Different Disease Sites in an Internal Validation Cohort.” In International Journal of Radiation Oncology*Biology*Physics, 102:S59–60. Elsevier BV, 2018. https://doi.org/10.1016/j.ijrobp.2018.06.168.
       Full Text
    • Rodrigues, A., C. Wang, Q. Wu, D. Limon, Y. M. Mowery, D. Niedzwiecki, and D. M. Brizel. “Adaptive IMRT Planning Improves Pharyngeal Sparing for Oropharyngeal Cancer.” In International Journal of Radiation Oncology*Biology*Physics, 102:e290–e290. Elsevier BV, 2018. https://doi.org/10.1016/j.ijrobp.2018.07.922.
       Full Text
    • Stephens, S. J., B. Czito, X. Zhang, E. Duffy, M. Malicki, B. Pitcher, D. Niedzwiecki, et al. “Surgical and Pathologic Outcomes in Patients on a Phase II Trial of Neoadjuvant Chemotherapy and Hypofractionated Image-Guided Intensity Modulated Radiation Therapy (HIGRT) in Resectable and Borderline Resectable Pancreatic Cancer.” In International Journal of Radiation Oncology*Biology*Physics, 102:S180–S180. Elsevier BV, 2018. https://doi.org/10.1016/j.ijrobp.2018.07.056.
       Full Text
    • Das, R. K., L. Furchtgott, F. -. S. Ou, D. Swanson, B. Hayete, B. Harms, D. Cunha, et al. “Causal modeling of CALGB/SWOG 80405 (Alliance) identifies primary (1 degrees) side-related angiogenic drivers of metastatic colorectal cancer (mCRC).” In Annals of Oncology, Vol. 29. OXFORD UNIV PRESS, 2018.
       Link to Item
    • Helzberg, James H., Alice Parish, Donna Niedzwiecki, Charles Y. Kim, Julius M. Wilder, and Andrew J. Muir. “TIPS Outcomes According to Race and Ethnicity.” In American Journal of Gastroenterology, 113:S496–S496. NATURE PUBLISHING GROUP, 2018.
       Link to Item
    • Innocenti, F., C. Jiang, A. B. Sibley, S. Denning, A. S. Etheridge, D. Watson, D. Niedzwiecki, et al. “A genetic analysis of gemcitabine-induced high-grade neutropenia in pancreatic cancer patients.” In Annals of Oncology, Vol. 29. OXFORD UNIV PRESS, 2018.
       Link to Item
    • Kappus, Matthew R., Kara Wegermann, Katie Charles, Yuval Patel, Gemini Janas, Erol Bozdogan, Alice Parish, Donna Niedzwiecki, Andrew Joseph Muir, and Mustafa Bashir. “Use of Skeletal Muscle Index As a Predictor of Waitlist Mortality in Patients with End-Stage Liver Disease.” In Hepatology, 68:658A-659A. WILEY, 2018.
       Link to Item
    • Muir, Andrew Joseph, Jia Yao, Julius Wilder, Christina Makarushka, Kelly Keefe, James Henry Helzberg, Paolo Mannelli, et al. “The Alcohol Use Disorders Identification Test Screening in Patients with Hepatitis C.” In Hepatology, 68:908A-908A. WILEY, 2018.
       Link to Item
    • Patel, Yuval, Jacqueline Henson, Julius Wilder, Matthew R. Kappus, Andrew S. Barbas, Cynthia A. Moylan, Donna Niedzwiecki, Andrew Joseph Muir, and Carl L. Berg. “The Impact of Advanced Age on Waiting List and Post-Transplantation Outcomes for NAFLD Patients.” In Hepatology, 68:683A-683A. WILEY, 2018.
       Link to Item
    • Yang, Nancy, Shai Posner, Alice Parish, Rahul Shimpi, Richard Wood, Thomas Finn, Deborah Fisher, et al. “Gastric Emptying Is Not Associated With Esophageal Motility Pattern or Patient Outcomes After Lung Transplantation.” In American Journal of Gastroenterology, 113:S227–S227. NATURE PUBLISHING GROUP, 2018.
       Link to Item
    • Jia, Jingquan, Donna Niedzwiecki, Hope Elizabeth Uronis, Michael Morse, Yousuf Zafar, Shiaowen David Hsu, Emily Bolch, et al. “A phase I/II trial of cabozantinib (C) with or without panitumumab (P) in patients (pts) with RAS wild-type (WT) metastatic colorectal cancer (mCRC): Clinical outcomes in pts with MET amplification (amp) detected in blood..” In Journal of Clinical Oncology, 36:3555–3555. American Society of Clinical Oncology (ASCO), 2018. https://doi.org/10.1200/jco.2018.36.15_suppl.3555.
       Full Text
    • Palta, Manisha, Brian G. Czito, Eileen Duffy, Mary Malicki, Donna Niedzwiecki, James L. Abbruzzese, Hope Elizabeth Uronis, Gerard C. Blobe, Dan G. Blazer, and Christopher Willett. “A phase II trial of neoadjuvant gemcitabine/nab-paclitaxel and SBRT for potentially resectable pancreas cancer: An evaluation of acute toxicity..” In Journal of Clinical Oncology, 36:4121–4121. American Society of Clinical Oncology (ASCO), 2018. https://doi.org/10.1200/jco.2018.36.15_suppl.4121.
       Full Text
    • Mettu, Niharika B., Donna Niedzwiecki, Patrick McKay Boland, Marwan Fakih, Christy Arrowood, Emily Bolch, Herbert Hurwitz, and Axel Grothey. “BACCI: A phase II randomized, double-blind, placebo-controlled study of capecitabine bevacizumab plus atezolizumab versus capecitabine bevacizumab plus placebo in patients with refractory metastatic colorectal cancer..” In Journal of Clinical Oncology, 36:TPS873–TPS873. American Society of Clinical Oncology (ASCO), 2018. https://doi.org/10.1200/jco.2018.36.4_suppl.tps873.
       Full Text
    • Nussbaum, D. P., Z. Sun, B. A. Yerokun, C. N. Rushing, D. Niedzwiecki, R. A. Greenup, and D. G. Blazer. “Measuring the Quality of Gastric Cancer Care in the United.” In Annals of Surgical Oncology, 25:S69–S69. SPRINGER, 2018.
       Link to Item
    • Sehdev, Amikar, Donna Niedzwiecki, Alan P. Venook, Heinz-Josef Lenz, Federico Innocenti, Michelle R. Mahoney, James Edward Shaw, et al. “Association of RAS mutations with race in metastatic colorectal cancer: CALGB/SWOG 80405 (ALLIANCE)..” In Journal of Clinical Oncology, 36:638–638. American Society of Clinical Oncology (ASCO), 2018. https://doi.org/10.1200/jco.2018.36.4_suppl.638.
       Full Text
    • Anand, Sarah, Samantha Thomas, Kelly Corbet, Cristina Gasparetto, Gwynn D. Long, Richard Lopez, Ashley K. Morris, et al. “Adult Umbilical Cord Blood Transplantation Using Myeloablative Thiotepa, Total Body Irradiation, and Fludarabine Conditioning..” In Biol Blood Marrow Transplant, 23:1949–54, 2017. https://doi.org/10.1016/j.bbmt.2017.06.027.
       Full Text  Link to Item
    • Nussbaum, Daniel P., Dan G. Blazer, Rachel A. Greenup, Zhifei Sun, Babatunde A. Yerokun, Christel Rushing, and Donna Niedzwiecki. “Quality in Cancer Care: An Assessment of the American College of Surgeons Commission on Cancer Quality Measures.” In Journal of the American College of Surgeons, 225:S125–S125. Elsevier BV, 2017. https://doi.org/10.1016/j.jamcollsurg.2017.07.275.
       Full Text
    • Grothey, A., A. Sobrero, J. A. Meyerhardt, T. Yoshino, J. Paul, J. Taieb, I. Souglakos, et al. “Prospective pooled analysis of six phase III trials investigating duration of adjuvant (adjuv) oxaliplatin-based therapy (3 vs 6 months) for patients (pts) with stage III colon cancer (CC): Updated results of IDEA (International Duration Evaluation of Adjuvant chemotherapy).” In Annals of Oncology, Vol. 28. OXFORD UNIV PRESS, 2017.
       Link to Item
    • Shi, Qian, Alberto F. Sobrero, Anthony Frank Shields, Takayuki Yoshino, James Paul, Julien Taieb, Ioannis Sougklakos, et al. “Prospective pooled analysis of six phase III trials investigating duration of adjuvant (adjuv) oxaliplatin-based therapy (3 vs 6 months) for patients (pts) with stage III colon cancer (CC): The IDEA (International Duration Evaluation of Adjuvant chemotherapy) collaboration..” In Journal of Clinical Oncology, 35:LBA1–LBA1. American Society of Clinical Oncology (ASCO), 2017. https://doi.org/10.1200/jco.2017.35.18_suppl.lba1.
       Full Text
    • Innocenti, Federico, Fang-Shu Ou, Tyler Zemla, Donna Niedzwiecki, Xueping Qu, Rachel Tam, Shilpi Mahajan, et al. “Somatic DNA mutations, MSI status, mutational load (ML): Association with overall survival (OS) in patients (pts) with metastatic colorectal cancer (mCRC) of CALGB/SWOG 80405 (Alliance)..” In Journal of Clinical Oncology, 35:3504–3504. American Society of Clinical Oncology (ASCO), 2017. https://doi.org/10.1200/jco.2017.35.15_suppl.3504.
       Full Text
    • Lenz, Heinz-Josef, Fang-Shu Ou, Alan P. Venook, Howard S. Hochster, Donna Niedzwiecki, Richard M. Goldberg, Robert J. Mayer, et al. “Impact of consensus molecular subtyping (CMS) on overall survival (OS) and progression free survival (PFS) in patients (pts) with metastatic colorectal cancer (mCRC): Analysis of CALGB/SWOG 80405 (Alliance)..” In Journal of Clinical Oncology, 35:3511–3511. American Society of Clinical Oncology (ASCO), 2017. https://doi.org/10.1200/jco.2017.35.15_suppl.3511.
       Full Text
    • Strickler, John H., Donna Niedzwiecki, Tyler Zemla, Andrea Cercek, Marwan Fakih, Kimmie Ng, Federico Augusto Sanchez, et al. “A phase II, open label study of tucatinib (ONT-380) combined with trastuzumab in patients with HER2+ metastatic colorectal cancer (mCRC)(MOUNTAINEER)..” In Journal of Clinical Oncology, 35:TPS3624–TPS3624. American Society of Clinical Oncology (ASCO), 2017. https://doi.org/10.1200/jco.2017.35.15_suppl.tps3624.
       Full Text
    • Van Blarigan, Erin, Charles S. Fuchs, Donna Niedzwiecki, Xing Ye, Sui Zhang, Mingyang Song, Leonard Saltz, et al. “American Cancer Society (ACS) Nutrition and Physical Activity Guidelines after colon cancer diagnosis and disease-free (DFS), recurrence-free (RFS), and overall survival (OS) in CALGB 89803 (Alliance)..” In Journal of Clinical Oncology, 35:10006–10006. American Society of Clinical Oncology (ASCO), 2017. https://doi.org/10.1200/jco.2017.35.15_suppl.10006.
       Full Text
    • Venook, Alan P., Fang-Shu Ou, Heinz-Josef Lenz, Omar Kabbarah, Xueping Qu, Donna Niedzwiecki, Tyler Zemla, et al. “Primary (1 degrees) tumor location as an independent prognostic marker from molecular features for overall survival (OS) in patients (pts) with metastatic colorectal cancer (mCRC): Analysis of CALGB / SWOG 80405 (Alliance)..” In Journal of Clinical Oncology, Vol. 35. AMER SOC CLINICAL ONCOLOGY, 2017. https://doi.org/10.1200/JCO.2017.35.15_suppl..3503.
       Full Text  Link to Item
    • Goodman, Karyn A., Donna Niedzwiecki, Nathan Hall, Tanios S. Bekaii-Saab, Xing Ye, Michael O. Meyers, Kisha Mitchell-Richards, et al. “Initial results of CALGB 80803 (Alliance): A randomized phase II trial of PET scan-directed combined modality therapy for esophageal cancer..” In Journal of Clinical Oncology, 35:1–1. American Society of Clinical Oncology (ASCO), 2017. https://doi.org/10.1200/jco.2017.35.4_suppl.1.
       Full Text
    • Guercio, Brendan John, Alan P. Venook, Donna Niedzwiecki, Sui Zhang, Kaori Sato, Charles S. Fuchs, Heinz-Josef Lenz, et al. “Associations of physical activity with survival and progression in metastatic colorectal cancer: Results from CALGB 80405 (Alliance)..” In Journal of Clinical Oncology, 35:659–659. American Society of Clinical Oncology (ASCO), 2017. https://doi.org/10.1200/jco.2017.35.4_suppl.659.
       Full Text
    • Van Blarigan, Erin, Charles S. Fuchs, Donna Niedzwiecki, Xing Ye, Sui Zhang, Mingyang Song, Leonard Saltz, et al. “Long-chain omega-3 fatty acid and fish intake after colon cancer diagnosis and disease-free, recurrence-free, and overall survival in CALGB 89803 (Alliance)..” In Journal of Clinical Oncology, 35:585–585. American Society of Clinical Oncology (ASCO), 2017. https://doi.org/10.1200/jco.2017.35.4_suppl.585.
       Full Text
    • Clarke, Jeffrey Melson, Gerard C. Blobe, John H. Strickler, Hope Elizabeth Uronis, Yousuf Zafar, Michael Morse, Evan Dropkin, et al. “Phase Ib study of regorafenib (rego) and PF-03446962 (PF) in patients with refractory metastatic colorectal cancer (mCRC) (REGAL)..” In Journal of Clinical Oncology, 34:e15013–e15013. American Society of Clinical Oncology (ASCO), 2016. https://doi.org/10.1200/jco.2016.34.15_suppl.e15013.
       Full Text
    • Nixon, Andrew B., Alexander Sibley, Ace Joseph Hatch, Yingmiao Liu, Chen Jiang, Flora Mulkey, Mark D. Starr, et al. “Blood-based biomarkers in patients (pts) with metastatic colorectal cancer (mCRC) treated with FOLFOX or FOLFIRI plus bevacizumab (Bev), cetuximab (Cetux), or Bev plus Cetux: Results from CALGB 80405 (Alliance)..” In Journal of Clinical Oncology, 34:3597–3597. American Society of Clinical Oncology (ASCO), 2016. https://doi.org/10.1200/jco.2016.34.15_suppl.3597.
       Full Text
    • Strickler, John H., Christel N. Rushing, Hope Elizabeth Uronis, Michael Morse, Gerard C. Blobe, Yousuf Zafar, Shiaowen David Hsu, et al. “Phase Ib study of cabozantinib plus panitumumab in KRAS wild-type (WT) metastatic colorectal cancer (mCRC)..” In Journal of Clinical Oncology, 34:3548–3548. American Society of Clinical Oncology (ASCO), 2016. https://doi.org/10.1200/jco.2016.34.15_suppl.3548.
       Full Text
    • Strickler, John H., Fatima A. Rangwala, Christel Rushing, Donna Niedzwiecki, Ivy Altomare, Hope Elizabeth Uronis, Shiaowen David Hsu, et al. “X-TRAP: Phase I/II study of capecitabine (X) plus ziv-aflibercept (TRAP) in metastatic colorectal cancer (mCRC)..” In Journal of Clinical Oncology, 34:687–687. American Society of Clinical Oncology (ASCO), 2016. https://doi.org/10.1200/jco.2016.34.4_suppl.687.
       Full Text
    • Innocenti, F., K. Owzar, J. Chen, A. Sibley, D. Niedzwiecki, M. Bertagnolli, P. Friedman, et al. “2007 A genome-wide association study (GWAS) of overall survival (OS) in 609 metastatic colorectal cancer (mCRC) patients treated with chemotherapy and biologics in CALGB 80405.” In European Journal of Cancer, 51:S329–30. Elsevier BV, 2015. https://doi.org/10.1016/s0959-8049(16)30932-7.
       Full Text
    • Heinemann, Volker, Donna Niedzwiecki, Rachel V. Pearline, Axel Grothey, Howard S. Hochster, Richard M. Goldberg, Federico Innocenti, et al. “Outcomes for FOLFIRI plus bevacizumab (BEV) or cetuximab (CET) in patients previously treated with oxaliplatin-based adjuvant therapy: A combined analysis of data from FIRE-3 and CALGB 80405..” In Journal of Clinical Oncology, 33:3585–3585. American Society of Clinical Oncology (ASCO), 2015. https://doi.org/10.1200/jco.2015.33.15_suppl.3585.
       Full Text
    • Innocenti, Federico, Kouros Owzar, Chen Jiang, Alexander Sibley, Donna Niedzwiecki, Heinz-Josef Lenz, Monica M. Bertagnolli, et al. “A genome-wide association study (GWAS) of overall survival (OS) in 609 metastatic colorectal cancer (mCRC) patients treated with chemotherapy and biologics in CALGB 80405..” In Journal of Clinical Oncology, 33:3599–3599. American Society of Clinical Oncology (ASCO), 2015. https://doi.org/10.1200/jco.2015.33.15_suppl.3599.
       Full Text
    • Kulke, Matthew H., Donna Niedzwiecki, Nathan R. Foster, Briant Fruth, Pamela L. Kunz, Hagen F. Kennecke, Edward M. Wolin, and Alan P. Venook. “Randomized phase II study of everolimus (E) versus everolimus plus bevacizumab (E+B) in patients (Pts) with locally advanced or metastatic pancreatic neuroendocrine tumors (pNET), CALGB 80701 (Alliance)..” In Journal of Clinical Oncology, 33:4005–4005. American Society of Clinical Oncology (ASCO), 2015. https://doi.org/10.1200/jco.2015.33.15_suppl.4005.
       Full Text
    • Ng, Kimmie, Alan P. Venook, Kaori Sato, Chen Yuan, Bruce W. Hollis, Donna Niedzwiecki, Cynthia Ye, et al. “Vitamin D status and survival of metastatic colorectal cancer patients: Results from CALGB/SWOG 80405 (Alliance)..” In Journal of Clinical Oncology, 33:3503–3503. American Society of Clinical Oncology (ASCO), 2015. https://doi.org/10.1200/jco.2015.33.15_suppl.3503.
       Full Text
    • Schrag, Deborah, Amylou C. Dueck, Michelle Joy Naughton, Donna Niedzwiecki, Craig Earle, James Edward Shaw, Axel Grothey, Howard S. Hochster, Charles David Blanke, and Alan P. Venook. “Cost of chemotherapy for metastatic colorectal cancer with either bevacizumab or cetuximab: Economic analysis of CALGB/SWOG 80405.” In Journal of Clinical Oncology, Vol. 33. AMER SOC CLINICAL ONCOLOGY, 2015.
       Link to Item
    • Ng, Kimmie, Alan P. Venook, Kaori Sato, Bruce W. Hollis, Donna Niedzwiecki, Cynthia Ye, I-Wen Chang, et al. “Vitamin D status and survival of metastatic colorectal cancer patients: Results from CALGB/SWOG 80405 (Alliance)..” In Journal of Clinical Oncology, 33:507–507. American Society of Clinical Oncology (ASCO), 2015. https://doi.org/10.1200/jco.2015.33.3_suppl.507.
       Full Text
    • Hatch, Ace Joseph, Herbert Pang, Mark D. Starr, John C. Brady, Jingquan Jia, Chen Jiang, Alexander Sibley, et al. “Prognostic and predictive blood-based biomarkers of overall survival (OS) in patients (pts) with advanced colorectal cancer (CRC) treated with cetuximab (C): Results from CALGB 80203 (Alliance)..” In Journal of Clinical Oncology, 32:11022–11022. American Society of Clinical Oncology (ASCO), 2014. https://doi.org/10.1200/jco.2014.32.15_suppl.11022.
       Full Text
    • Venook, Alan P., Donna Niedzwiecki, Heinz-Josef Lenz, Federico Innocenti, Michelle R. Mahoney, Bert H. O’Neil, James Edward Shaw, et al. “CALGB/SWOG 80405: Phase III trial of irinotecan/5-FU/leucovorin (FOLFIRI) or oxaliplatin/5-FU/leucovorin (mFOLFOX6) with bevacizumab (RV) or cetuximab (CET) for patients (pts) with KRAS wild-type (wt) untreated metastatic adenocarcinoma of the colon or rectum (MCRC)..” In Journal of Clinical Oncology, Vol. 32. AMER SOC CLINICAL ONCOLOGY, 2014.
       Link to Item
    • Hatch, Ace J., Herbert Pang, Mark D. Starr, John C. Brady, Jingquan Jia, Donna Niedzwiecki, Alan Paul Venook, Stephanie M. Cushman, Herbert Hurwitz, and Andrew B. Nixon. “Prognostic and predictive blood-based biomarkers of overall survival (OS) in patients (pts) with advanced colorectal cancer (CRC) treated with cetuximab (C): Results from CALGB 80203 (Alliance)..” In Journal of Clinical Oncology, 32:448–448. American Society of Clinical Oncology (ASCO), 2014. https://doi.org/10.1200/jco.2014.32.3_suppl.448.
       Full Text
    • Niedzwiecki, Donna, Wendy Frankel, Alan Paul Venook, Xing Ye, Paula N. Friedman, Richard M. Goldberg, Robert J. Mayer, et al. “Association between ColDx assay result and recurrence-free interval in stage II colon cancer patients on CALGB (Alliance) 9581..” In Journal of Clinical Oncology, 32:455–455. American Society of Clinical Oncology (ASCO), 2014. https://doi.org/10.1200/jco.2014.32.3_suppl.455.
       Full Text
    • Hurwitz, Herbert, Stephanie Cushman, Chen Jiang, Ivo Shterev, Michelle R. Mahoney, Donna Niedzwiecki, Robert J. Mayer, Alan Paul Venook, Kouros Owzar, and Andrew B. Nixon. “Tumor markers of efficacy and resistance to cetuximab (C) treatment in metastatic colorectal cancer (mCRC): Results from CALGB 80203 (Alliance).” In Journal of Clinical Oncology, Vol. 31. AMER SOC CLINICAL ONCOLOGY, 2013.
       Link to Item
    • Naughton, Michelle Joy, Deborah Schrag, Alan Paul Venook, Donna Niedzwiecki, Roger T. Anderson, Heinz-Josef Lenz, and Stephen S. Grubbs. “Quality of life (QOL) and toxicity among patients in CALGB 80405.” In Journal of Clinical Oncology, Vol. 31. AMER SOC CLINICAL ONCOLOGY, 2013.
       Link to Item
    • Van Loon, Katherine, Kouros Owzar, Chen Jiang, Hedy Lee Kindler, Mary Frances Mulcahy, Donna Niedzwiecki, Eileen Mary O’Reilly, Charles S. Fuchs, Federico Innocenti, and Alan Paul Venook. “25-hydroxyvitamin D levels and survival in patients with advanced pancreatic cancer (APC): Findings from CALGB 80303.” In Journal of Clinical Oncology, Vol. 31. AMER SOC CLINICAL ONCOLOGY, 2013.
       Link to Item
    • Morse, Michael, Amy Hobeika, Arvind Chaudhry, Andrea Amalfitano, Donna Niedzwiecki, Timothy M. Clay, Takuya Osada, et al. “Effect of the vaccine Ad5 [E1-, E2b-]-CEA(6D) on CEA-directed CMI responses in patients with advanced CEA-expressing malignancies in a phase I/II clinical trial.” In Journal of Clinical Oncology, Vol. 30. AMER SOC CLINICAL ONCOLOGY, 2012.
       Link to Item
    • Kanda, Junya, David A. Rizzieri, Gwynn D. Long, Cristina Gasparetto, John P. Chute, Keith M. Sullivan, Ashley Morris, et al. “The Impact of Lymphocyte Subset Recovery At 3 Months on Progression-Free Survival After Myeloablative Allogeneic Stem Cell Transplantation.” In Blood, 118:1736–1736. AMER SOC HEMATOLOGY, 2011.
       Link to Item
    • Mahmoud, N. N., M. Lopatin, K. Clark-Langone, M. Lee, D. Niedzwiecki, and A. P. Venook. “1411 POSTER Endpoints for Validation of Tumour Markers for Recurrence Risk -Recurrence-free Interval (RFI), Disease-free Survival (DFS), Overall Survival (OS), and Colon-cancer Specific Survival (CCSS) in CALGB 9581.” In European Journal of Cancer, 47:S172–S172. Elsevier BV, 2011. https://doi.org/10.1016/s0959-8049(11)70904-2.
       Full Text
    • Lyerly, H. K., A. Hobeika, D. Niedzwiecki, T. Osada, J. Marshall, C. R. Garrett, D. Z. Chang, et al. “A dendritic cell-based vaccine effects on T-cell responses compared with a viral vector vaccine when administered to patients following resection of colorectal metastases in a randomized phase II study..” In Journal of Clinical Oncology, 29:2533–2533. American Society of Clinical Oncology (ASCO), 2011. https://doi.org/10.1200/jco.2011.29.15_suppl.2533.
       Full Text
    • Morse, M., D. Niedzwiecki, J. Marshall, C. R. Garrett, D. Z. Chang, M. Aklilu, T. S. Crocenzi, et al. “Survival rates among patients vaccinated following resection of colorectal cancer metastases in a phase II randomized study compared with contemporary controls..” In Journal of Clinical Oncology, 29:3557–3557. American Society of Clinical Oncology (ASCO), 2011. https://doi.org/10.1200/jco.2011.29.15_suppl.3557.
       Full Text
    • Chiou, Lun-Wei, Junya Kanda, Paul Szabolcs, Gregory E. Sempowski, Jeffrey Hale, Donna Niedzwiecki, Gloria Broadwater, Nelson J. Chao, and Mitchell E. Horwitz. “A Comprehensive Comparison Immune Recovery In Adult Patients Following Allogeneic Umbilical Cord Blood, Matched Sibling and Matched Unrelated Donor Stem Cell Transplantation.” In Blood, 116:954–55. AMER SOC HEMATOLOGY, 2010.
       Link to Item
    • Castor, John, Richard Wood, Donna Niedzwiecki, Andrew Muir, Scott Palmer, and Rahul Shimpi. “Lung Transplantation Alters Esophageal Motility and is Associated with Abnormal pH Testing.” In American Journal of Gastroenterology, 105:S13–14. Ovid Technologies (Wolters Kluwer Health), 2010. https://doi.org/10.14309/00000434-201010001-00035.
       Full Text
    • Morse, M., A. Hobeika, T. Osada, P. Berglund, S. Negri, D. Niedzwiecki, B. Hubby, B. K. Burnett, T. M. Clay, and H. K. Lyerly. “Effect of a novel recombinant alphaviral vector on tolerance to self-antigen in the setting of elevated regulatory T cells..” In Journal of Clinical Oncology, 28:2544–2544. American Society of Clinical Oncology (ASCO), 2010. https://doi.org/10.1200/jco.2010.28.15_suppl.2544.
       Full Text
    • Bertagnolli, M. M., D. Niedzwiecki, M. Hall, S. D. Jewell, R. J. Mayer, R. M. Goldberg, T. A. Colacchio, R. S. Warren, and M. Redston. “Presence of 18q loss of heterozygosity (LOH) and disease-free and overall survival in stage II colon cancer: CALGB Protocol 9581.” In Journal of Clinical Oncology, Vol. 27. AMER SOC CLINICAL ONCOLOGY, 2009.
       Link to Item
    • Fuchs, C., S. Ogino, J. A. Meyerhardt, N. Irahara, D. Niedzwiecki, D. Hollis, L. B. Saltz, R. J. Mayer, and M. M. Bertagnolli. “KRAS mutation, cancer recurrence, and patient survival in stage III colon cancer: Findings from CALGB 89803.” In Journal of Clinical Oncology, Vol. 27. AMER SOC CLINICAL ONCOLOGY, 2009.
       Link to Item
    • Clay, T. M., A. Hobeika, T. Osada, D. Serra, D. Niedzwiecki, H. K. Lyerly, and M. A. Morse. “Depletion of human regulatory T cells (Treg) and antigen-specific immune responses to cancer vaccines.” In Journal of Clinical Oncology, Vol. 26, 2008. https://doi.org/10.1200/jco.2008.26.15_suppl.3010.
       Full Text  Link to Item
    • Mohamed, A., D. Niedzwiecki, J. H. Baker, R. Vinesett, P. L. Martin, T. A. Driscoll, V. K. Prasad, S. Parikh, J. Kurtzberg, and P. Szabolcs. “208: The Use, Safety, and Efficacy of Daclizumab for Steroid Refractory Graft-Versus-Host-Disease (GVHD) after Unrelated Cord Blood Transplantation (UCBT).” In Biology of Blood and Marrow Transplantation, 14:77–77. Elsevier BV, 2008. https://doi.org/10.1016/j.bbmt.2007.12.217.
       Full Text
    • Meyerhardt, J. A., D. Niedzwiecki, D. Hollis, L. Saltz, W. Willett, R. J. Mayer, and C. S. Fuchs. “The impact of dietary patterns on cancer recurrence and survival in patients with stage III colon cancer: Findings from CALGB 89803.” In Journal of Clinical Oncology, Vol. 25. AMER SOC CLINICAL ONCOLOGY, 2007.
       Link to Item
    • Posner, M. C., D. Niedzwiecki, A. P. Venook, D. R. Hollis, R. L. Schilsky, R. M. Goldberg, and R. J. Mayer. “A phase II prospective, multi-institutional trial (CALGB 89903) of adjuvant active specific immunotherapy following curative resection of colorectal cancer(CRC) hepatic metastases.” In Annals of Surgical Oncology, 14:3–3. SPRINGER, 2007.
       Link to Item
    • Damon, Lloyd E., Jeff Johnson, Donna Niedzwiecki, Bruce D. Cheson, David Duane Hurd, Nancy L. Bartlett, John C. Byrd, Michael Kelly, Charles Linker, and George P. Canellos. “Immuno-Chemotherapy (IC) and Autologous Stem Cell Transplant (ASCT) for Untreated Patients (pts) with Mantle Cell Lymphoma (MCL): CALGB 59909..” In Blood, 108:2737–2737. American Society of Hematology, 2006. https://doi.org/10.1182/blood.v108.11.2737.2737.
       Full Text
    • Szabolcs, Paul, Bercedis L. Peterson, Donna Niedzwiecki, Nelson Chao, and Joanne Kurtzberg. “Multivariate Analysis of Patient and Graft Specific Factors among 330 Recipients of Unrelated Cord Blood Transplant (UCBT) To Predict Risk of Death from Opportunistic Infections in the First 6 Months after UCBT..” In Blood, 108:2860–2860. American Society of Hematology, 2006. https://doi.org/10.1182/blood.v108.11.2860.2860.
       Full Text
    • Bertagnolli, M. M., C. C. Compton, D. Niedzwiecki, R. S. Warren, S. Jewell, G. P. Bailey, R. J. Mayer, R. Goldberg, L. Saltz, and M. Redston. “Microsatellite instability predicts improved response to adjuvant therapy with irinotecan, 5-fluorouracil and leucovorin in stage III colon cancer..” In Journal of Clinical Oncology, 24:541S-541S. AMER SOC CLINICAL ONCOLOGY, 2006.
       Link to Item
    • Blum, K. A., J. L. Johnson, D. Niedzwiecki, G. P. Cannellos, B. D. Cheson, and N. L. Bartlett. “A phase II study of bortezomib in relapsed Hodgkin lymphoma: Preliminary results of CALGB 50206..” In Journal of Clinical Oncology, 24:440S-440S. AMER SOC CLINICAL ONCOLOGY, 2006.
       Link to Item
    • Gajewski, T. F., D. Niedzwiecki, J. Johnson, G. Linette, C. Bucher, M. Blaskovich, S. Sebti, and F. Haluska. “Phase II study of the farnesyltransferase inhibitor R115777 in advanced melanoma: CALGB 500104..” In Journal of Clinical Oncology, 24:456S-456S. AMER SOC CLINICAL ONCOLOGY, 2006.
       Link to Item
    • Tepper, J. E., M. Krasna, D. Niedzwiecki, D. Hollis, C. Reed, R. Goldberg, T. Rich, K. Kiel, and R. Mayer. “Superiority of trimodality therapy to surgery alone in esophageal cancer: Results of CALGB 9781..” In Journal of Clinical Oncology, 24:181S-181S. AMER SOC CLINICAL ONCOLOGY, 2006.
       Link to Item
    • Venook, A., D. Niedzwiecki, D. Hollis, S. Sutherland, R. Goldberg, S. Alberts, A. Benson, J. Wade, R. Schilsky, and R. Mayer. “Phase III study of irinotecan/5FU/LV (FOLFIRI) or oxaliplatin/5FU/LV (FOLFOX) +/- cetuximab for patients (pts) with untreated metastatic adenocarcinoma of the colon or rectum (MCRC): CALGB 80203 preliminary results..” In Journal of Clinical Oncology, 24:148S-148S. AMER SOC CLINICAL ONCOLOGY, 2006.
       Link to Item
    • Rizzieri, D., J. Chute, M. Horwitz, C. Gasparetto, K. Sullivan, G. Long, A. Morris, D. Niedzwiecki, and C. Nelson. “Non-myeloablative allogeneic transplantation with alemtuzumab, fludarabine and cyclophosphamide using 3-6/6 HLA matched donors.” In Biology of Blood and Marrow Transplantation, 12:34–34. Elsevier BV, 2006. https://doi.org/10.1016/j.bbmt.2005.11.104.
       Full Text
    • Rizzieri, D. A., L. P. Koh, G. D. Long, C. Gasparetto, K. M. Sullivan, M. Horwitz, J. Chute, et al. “Partially HLA matched, non-myeloablative allogeneic transplantation.” In Blood, 106:812A-812A. AMER SOC HEMATOLOGY, 2005.
       Link to Item
    • Rizzieri, David A., Liang Piu Koh, Gwynn D. Long, Cristina Gasparetto, Jerald Z. Gong, Anand S. Lagoo, Donna Niedzwiecki, et al. “Outcome and Immune Reconstitution Following T Cell Depleted Nonmyeloablative Allogeneic Transplantation Using Matched Donors..” In Blood, 106:2036–2036. American Society of Hematology, 2005. https://doi.org/10.1182/blood.v106.11.2036.2036.
       Full Text
    • Mamon, H. J., D. Niedzwiecki, D. R. Hollis, B. Tan, J. Smith, A. W. Blackstock, J. E. Tepper, R. M. Goldberg, R. J. Mayer, and C. S. Fuchs. “Preliminary Analysis of Cancer and Leukemia Group B (CALGB) 80003: A Phase II Trial of Gemcitabine, 5-Fluorouracil (5FU), and Radiation Therapy (RT) in Locally Advanced Non-Metastatic Pancreatic Adenocarcinoma.” In International Journal of Radiation Oncology*Biology*Physics, 63:S13–S13. Elsevier BV, 2005. https://doi.org/10.1016/j.ijrobp.2005.07.028.
       Full Text
    • Fuchs, C., J. A. Meyerhardt, D. L. Heseltine, D. Niedzwiecki, D. Hollis, A. T. Chan, L. B. Saltz, R. L. Schilsky, and R. J. Mayer. “Influence of regular aspirin use on survival for patients with stage III colon cancer: Findings from Intergroup trial CALGB 89803..” In Journal of Clinical Oncology, 23:253S-253S. AMER SOC CLINICAL ONCOLOGY, 2005.
       Link to Item
    • Meyerhardt, J. A., D. Heseltine, D. Niedzwiecki, D. Hollis, L. B. Saltz, R. J. Mayer, R. L. Schilsky, and C. S. Fuchs. “The impact of physical activity on patients with stage III colon cancer: Findings from Intergroup trial CALGB 89803..” In Journal of Clinical Oncology, 23:254S-254S. AMER SOC CLINICAL ONCOLOGY, 2005.
       Link to Item
    • Wilson, W. H., P. Porcu, D. Hurd, S. E. Martin, M. Czuczman, D. Niedzwiecki, J. D. Saint Louis, et al. “Phase II study of dose-adjusted EPOCH-R in untreated de novo CD20+ diffuse large B-cell lymphoma (DLBCL)-CALGB 50103..” In Journal of Clinical Oncology, 23:567S-567S. AMER SOC CLINICAL ONCOLOGY, 2005.
       Link to Item
    • Szabolcs, P., K. -. D. Park, D. Niedzwiecki, L. Sanders, Y. -. A. Lee, L. Marti, M. Reese, and J. Kurtzberg. “Dendritic cell and T-cell subsets correlate with the development and site of acute GVHD following unrelated cord blood transplantation in children: A multivariate analysis.” In Biology of Blood and Marrow Transplantation, 11:81–81. Elsevier BV, 2005. https://doi.org/10.1016/j.bbmt.2004.12.240.
       Full Text
    • Czuczman, M. S., P. Porcu, J. Johnson, D. Niedzwiecki, G. P. Canellos, and B. D. Cheson. “CALGB 59901: Results of a phase II study of 506U78 in CTCL and PTCL..” In Blood, 104:682A-682A. AMER SOC HEMATOLOGY, 2004.
       Link to Item
    • Damon, Lloyd, Donna Niedzwiecki, Jeff Johnson, Bruce Cheson, David Hurd, Nancy Barlett, Michael Kelly, Charles Linker, and George Canellos. “Intense Immunochemotherapy (IC) and Autologous Stem Cell Transplant (ASCT) for Untreated Patients (pts) with Mantle Cell Lymphoma (MCL): CALGB 59909. A Preliminary Report..” In Blood, 104:895–895. American Society of Hematology, 2004. https://doi.org/10.1182/blood.v104.11.895.895.
       Full Text
    • Koh, Liang-Piu, Jon P. Gockerman, Joseph O. Moore, Carlos DeCastro, Gwynn D. Long, Cristina Gasparetto, Donna Niedzwiecki, et al. “Dose Dense, High Intensity Induction Therapy Followed by Early High Dose Chemotherapy (HDT) and Autologous Hematopoietic Stem Cell Transplantation(AHSCT) for Mantle Cell Lymphoma (MCL)..” In Blood, 104:913–913. American Society of Hematology, 2004. https://doi.org/10.1182/blood.v104.11.913.913.
       Full Text
    • Smith, Sonali M., Jeffrey L. Johnson, Donna Niedzwiecki, J Paul Eder, George P. Canellos, Bruce D. Cheson, and Nancy L. Bartlett. “Sequential Topoisomerase I (Topo I) and Topoisomerase II (Topo II) Inhibitors in Relapsed/Refractory Aggressive NHL: Results of CALGN 59906, a Phase II Study of Doxorubicin and Topotecan..” In Blood, 104:2500–2500. American Society of Hematology, 2004. https://doi.org/10.1182/blood.v104.11.2500.2500.
       Full Text
    • Szabolcs, Paul, Kyung-Duk Park, Luciana Marti, Young-Ah Lee, Melissa Reese, Linda Sanders, Donna Niedzwiecki, and Joanne Kurtzberg. “Dendritic and T Cell Subsets Correlate with the Development and Site of Acute GVHD Following Unrelated Cord Blood Transplantation. A Multivariate Analysis of Host, Graft, and Day+50 Immune Profile..” In Blood, 104:981–981. American Society of Hematology, 2004. https://doi.org/10.1182/blood.v104.11.981.981.
       Full Text
    • Bertagnolli, M. M., M. Redston, B. Miedema, J. Dowell, D. Niedzwiecki, R. Mayer, J. Fleshman, J. Bem, and C. Compton. “Sentinel node staging of resectable colon cancer: Results of CALGB 80001..” In Journal of Clinical Oncology, 22:246S-246S. AMER SOC CLINICAL ONCOLOGY, 2004.
       Link to Item
    • Colacchio, T. A., D. Niedzwiecki, C. Compton, R. Warren, A. I. B. Benson, R. Goldberg, D. Kerr, A. Fields, D. Hollis, and R. Mayer. “Phase III trial of adjuvant immunotherapy with MOAb 17-1A following resection for stage II adenocarcinoma of the colon (CALGB 9581)..” In Journal of Clinical Oncology, 22:250S-250S. AMER SOC CLINICAL ONCOLOGY, 2004.
       Link to Item
    • Kulke, M. H., D. Niedzwiecki, M. A. Tempero, D. R. Hollis, and R. J. Mayer. “A randomized phase II study of gemcitabine/cisplatin, gemcitabine fixed dose rate infusion, gemcitabine/docetaxel, or gemcitabinefirinotecan in patients with metastatic pancreatic cancer (CALGB 89904)..” In Journal of Clinical Oncology, 22:316S-316S. AMER SOC CLINICAL ONCOLOGY, 2004.
       Link to Item
    • Ryan, D. P., D. Niedzwiecki, D. Hollis, B. E. Miedema, S. Wadler, J. E. Tepper, and R. J. Mayer. “A phase I/II study of preoperative oxaliplatin (0), 5-fluorouracil (5-FU), and external beam radiation therapy (XRT) in locally advanced rectal cancer: CALGB 89901..” In Journal of Clinical Oncology, 22:260S-260S. AMER SOC CLINICAL ONCOLOGY, 2004.
       Link to Item
    • Saltz, L. B., D. Niedzwiecki, D. Hollis, R. M. Goldberg, A. Hantel, J. P. Thomas, A. L. A. Fields, G. Carver, and R. J. Mayer. “Irinotecan plus fluorouracil/leucovorin (IFL) versus fluorouracil/leucovorin alone (FL) in stage III colon cancer (intergroup trial CALGB C89803)..” In Journal of Clinical Oncology, 22:245S-245S. AMER SOC CLINICAL ONCOLOGY, 2004.
       Link to Item
    • Szaboles, P., K. D. Park, M. Reese, L. Marti, L. Sanders, D. Niedzwiecki, Y. Lee, D. DeOliveira, and J. Kurtzberg. “Immune reconstitution and the risk of opportunistic infections after unrelated cord blood transplantation. A multivariate analysis.” In Faseb Journal, 18:A829–A829. FEDERATION AMER SOC EXP BIOL, 2004.
       Link to Item
    • Szabolcs, P., K. D. Park, L. Marti, M. Reese, Y. A. Lee, D. D. Oliveira, L. Sanders, D. Niedzwiecki, and J. Kutzberg. “The impact of immune reconstitution in the early post grafting period on the development of opportunistic infections after unrelated cord blood transplantation. A multivariate analysis of host, graft, and day +50 immune profile.” In Biology of Blood and Marrow Transplantation, 10:24–24. Elsevier BV, 2004. https://doi.org/10.1016/j.bbmt.2003.12.099.
       Full Text
    • Rizzieri, D. A., G. Akabani, M. Zalutsky, R. E. Coleman, B. Toaso, E. Anderson, A. Lagoo, et al. “Phase I trial with pharmocokinetics, dosimetry, toxicity and response of anti-stromal therapy using I-131 labeled chimeric anti-tenascin therapy for lymphoma..” In Blood, 102:635A-636A. AMER SOC HEMATOLOGY, 2003.
       Link to Item
    • Rizzieri, D. A., G. J. Sand, D. McGaughey, J. Moore, C. DeCastro, N. Chao, J. Vredenburgh, et al. “Low-dose weekly paclitaxel for relapsed or refractory aggressive non-Hodgkins lymphoma..” In Blood, 102:641A-641A. AMER SOC HEMATOLOGY, 2003.
       Link to Item
    • Rizzieri, D. A., L. P. Koh, G. D. Long, C. Gasparetto, J. J. Vredenburgh, P. J. Buckley, G. Gong, et al. “Clinical outcome and immune reconstitution following alemtuzumab T cell depleted nonmyeloablative allogeneic immunotherapy using HLA mis-matched (3-5/6) related hematopoietic stem cells..” In Blood, 102:482A-482A. AMER SOC HEMATOLOGY, 2003.
       Link to Item
    • Szabolcs, P., K. D. Park, L. Marti, M. Reese, L. Sanders, D. Niedzwiecki, and J. Kurtzberg. “Early T cell reconstitution along with graft and patient characteristics impact on opportunistic infections following unrelated cord blood transplantation in children.” In Faseb Journal, 17:C59–C59. FEDERATION AMER SOC EXP BIOL, 2003.
       Link to Item
    • Szabolcs, P., K. D. Park, M. Reese, L. Marti, L. Sanders, D. Niedzwiecki, and J. Kurtzberg. “Early T cell reconstitution along with graft and patient characteristics impact on opportunistic infections following unrelated cord blood transplantation in children..” In Blood, 100:841A-841A. AMER SOC HEMATOLOGY, 2002.
       Link to Item
    • Zhen, S., J. Dannull, D. Coleman, J. Higgins, D. Yancey, S. Pruitt, A. Weizer, D. Niedzwiecki, E. Gilboa, and J. Vieweg. “Immunological and clinical responses in patients with metastatic renal cell carcinoma to vaccination with tumor RNA transfected dendritic cells..” In Blood, 100:867A-867A. AMER SOC HEMATOLOGY, 2002.
       Link to Item

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.